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Abstract 
Amygel® is an injectable biodegradable controlled release drug delivery system 
with adjustable release kinetics determined by varying the concentrations of the 
polymeric components of the material.  Amygel® is a starch based biodegradable 
hydrogel consisting of an interpenetrating network of physically entangled amylose and 
amylopectin polymer chains crosslinked with d-glucaric acid.  Amylose and amylopectin 
are the two components of naturally occurring starch. The immiscibility of the amylose 
and amylopectin due to differences in solubility parameter and chain size induces phase 
separation within the network but because the chains entangled during hydrolysis an 
interpenetrating network is formed.  The chemically reactive carboxyl groups of the d-
glucaric acid react with the –OH groups of the amylose and amylopectin chains via 
condensation creating an ester linkage.  This ester linkage degrades according to the same 
hydrolytic mechanism of the main chain backbone resulting in the release of di-acid 
while the hydrolysis of the acetal bonds of the amylose and the amylopectin results in the 
generation of glucose monomers, maltose dimers, and maltotriose trimers which can all 
be safely consumed by the surrounding cells in the tissue. Raman Spectroscopy confirms 
the formation of ester linkages with the addition of d-glucaric acid to starch gels.  With 
the addition of the chemical crosslinker, the elastic modulus of the starch hydrogel 
increases.  Also, with increased crosslink concentration, the degradation time of the 
system is extended.  D-glucaric acid is a proven anti-carcinogenic agent, and there is 
evidence that Amygel® inhibits the cell proliferation of osteosarcomas by up to 70%.  
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 I.  Introduction 
 Recent advancements in medicine have gone beyond oral and injectable systemic 
delivery of therapeutic pharmaceutical agents to treat disease and are currently pursuing 
avenues of drug delivery directly to the site of affected organs, tissues and cells.  Polymer 
Engineering and Biomaterials research has contributed greatly to the areas of medicine 
and pharmaceutical science through the development of novel materials and material 
systems that can be used as vehicles of drug delivery.  The system described in this paper 
is a novel biodegradable hydrogel made of natural polymers that has two-fold drug 
delivery capabilities.  One, the material has the ability to complex with pharmaceutical 
compounds, so the gel can be loaded with a specific drug to be delivered to treat a 
particular disease at a targeted site . Two, the degradation product of the chemical 
crosslinker of the hydrogel is a proven therapeutic agent effective against carcinogenic 
cells. 
Carcinogenesis 
 
 The induction of cancer depends on inherited and acquired susceptibility factors, 
on exposure to initiation factors, and on promotion and progression factors.  Malignant 
neoplasia is the result of multiple genetic defects successively accumulating over a period 
of time.  It is now apparent that the cellular evolution to malignancy involves the 
sequential alteration of proto-oncogenes and/or tumor suppressor genes whose gene 
products participate in critical pathways for the transduction of signals and/or regulation 
of gene expression [Walaszek 2004].  These stages have been defined experimentally as 
initiation, promotion, and progression. 
 2
  Initiation involves mutation of cellular DNA resulting in the activation of 
oncogenes and the inactivation of tumor suppressor genes [Walaszek 2004].  Initiation is 
thought to be irreversible and consists of a single gene mutation that is caused in most 
cases by environmental genotoxic agents such as chemicals, radiation, and viruses.  
Oncogenes can also be activated by chromosomal translocations and gene amplifications 
[Walaszek 2004].   
 Promotion follows initiation and involves the process of gene activation, such that 
the latent phenotype of the initiated cell becomes expressed through cellular selection and 
clonal expansion.  This can occur through a variety of mechanisms including toxicity, 
terminal differentiation or mitotic inhibition of the noninitiated cells, and mitogenesis of 
the initiated cells [Walaszek 2004].  While promotion occurs over a long period of time, it is 
reversible in its early stages.  Proof that promotion is reversible in humans is supported 
by the observation that the rate of lung cancer induction in individuals who quit smoking 
approaches that of nonsmokers [Walaszek 2004].  The breadth of the available data, as well as 
the multistage nature of tumor promotion suggests that this process may involve the 
interaction of a number of endogenous factors as well as environmental factors such as 
chemicals, radiation, viruses, bacteria, and diet and nutrition.  In human cancer, smoking, 
alcoholic beverages, diet and nutrition and environmental factors such as asbestos, 
hydrocarbons, radiation, and hormones are now thought to have more of a promotional 
influence in the multistage process of carcinogenesis [Walaszek 2004]. 
 The last step leading to cancer is called progression.  Progression involves genetic 
damage that results in the conversion of benign cells into malignant neoplasms capable of 
invading adjacent tissues and metastasizing to distant sites.  The additional genetic 
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alterations thought to be required for neoplastic progression often occur faster than would 
be expected from the statistics of accidental genotoxic insults due to so-called genetic 
instability.  The concept of genetic instability implies that while environmental genotoxic 
agents generally cause cancer initiation, the additional mutations required for neoplastic 
progression may be attributed to endogenous reactions and factors such as detoxification 
and removal of damaged cells by programmed cell death [Walaszek 2004].  Genetic instability 
may be a result of errors in DNA replication or spontaneous hydrolytic alterations of 
DNA such as depurination and deamination in combination with an impaired ability of 
pre-malignant cells to repair DNA damage.  Modified DNA bases, especially 8-hydroxy-
2’-deoxyguanosice, produced by oxygen-free radicals have been implicated in the 
initiation of cancer.  The importance of free radicals in radiation carcinogenesis and 
oxygen-free radicals and electrophiles in chemical carcinogenesis is also well recognized 
[Walaszek 2004]. 
 Chemoprevention, namely inhibition or reversal of carcinogenesis, may be 
conducted at a variety of time points in this process to reduce occurrence of invasive 
cancers - primary intervention at earlier stages in the process or secondary intervention at 
later stages in the process.  Chemoprevention applies to the prevention of clinical cancer 
by the administration of pharmaceuticals or dietary constituents.  The efficacy of such 
preventive interventions is evaluated in clinical trials.  Phase I trials determine the dose-
related safety of drugs and frequently include pharmacokinetic studies.  Phase II and III 
trials are used to test drug activity.  Agents used in successful Phase II clinical trials have 
evidence of chemopreventive efficacy and the high likelihood of the agent preventing 
 4
cancer at the target site [Walaszek 2004].  All experimental treatments must have a high 
margin of safety and a logical presumed mechanism of chemopreventive activity.    
 The mechanisms that focus on initiation events include (a) inhibition or alteration 
of phase I enzymes responsible for the formation of reactive carcinogenic metabolites; (b) 
inhibition or induction of oxidative enzyme pathways that produce products of lower 
carcinogenic potential; (c) induction of detoxification enzymes, phase II enzymes and 
pathways for both proximate and ultimate carcinogen; (d) scavenging of reactive 
carcinogenic intermediates  through direct chemical interaction; (e)  inhibition or 
enhancement of DNA repair mechanisms; and (f) inhibition of cell proliferation and 
DNA synthesis [Hanausek 2003].  Realistically, there is a higher degree of success when 
treated with combinations of compounds that can act through one or more different 
mechanisms. 
 Table 1 lists a number of potent inhibitors of tumor initiation that appear to be 
effective because they prevent the formation of the ultimate carcinogen [Walaszek 2004]. 
 Some phenolic antioxidants have been extensively studied, primarily because of their use 
as food preservatives.  In addition to the alterations in oxidative metabolism, the phenolic 
antioxidants have also been shown to increase the detoxification pathways for many 
chemical carcinogens.  The indoles, aromatic isothiocyanates, coumarines, flavones, di 
and triterpenoids, dithiothiones, organosulfides, chlorophyllin, and D-glucarates have a 
potent effect on the body’s metabolism of carcinogens [Walaszek 2004].   In general, they 
appear to have a major effect on the detoxification of carcinogens.  Ellagic acid, 2,6-
dithiopurin, and chlorophyllin have been also shown to be highly potent in scavenging 
the ultimate reactant carcinogenic form of carcinogens [Walaszek 2004].  Disulfiram, vitamin  
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Table 1. Table of Anti-tumor Compounds According to Mechanism of Inhibition. 
Prevention Strategy Examples 
Tumor Initiation  
         -Inhibit carcinogen activity Epigallocatechin gallate (EGCG), Selenium, 
Phehtyl-isothiocyanate (PEITC), Indol-3-
carbinol, Coumarins, Ellagic Acid, 
Resveretrol, Genistein, 1-ethynylpyrene 
         -Scavenge electrophiles Ellagic Acid, EGCG, 2,6-dithiopurine, 
Chlorophyllin 
         -Enhance Carcinogen Detoxfication Oltipraz, Diallyl Sulfide (DAS), EGCG, 
PEITC, N-acetylcysteine (NAS), D-
glucarate, Resveratrol 
         -Enhance DNA repair Calorie Restriction, EGCG, Selenium 
Tumor Promotion / Progression  
         -Scavenge Reactive Oxygen Species Antioxidants (Carotenoids, α-tocopherol, 
Ascorbic Acid, Chlorophyllin, α-lipoic 
Acid, Proanthocyanidins, EGCG, Avicins, 
Selenium, Calorie Restriction) 
         -Alter Gene Expression Retinoids (all-trans Retinoic Acids, 
Fenretinide), Calorie Restriction, 
Monoterpenes, Fluasterone, 
Dehydroepiandrosterone (DHEA) 
         -Decrease Inflammation Steroidal anti-inflammatory, Non-steroidal 
Anti-inflammatory drugs (NSAIDs), Calorie 
Restriction, DHEA, Fluasterone, 
Antihistamines 
         -Suppress Proliferation Calorie Restriction, Selenium, DHEA, 
Difluoromethylomithine (DFMO), 
Tamoxifen, Genistein, Fluasterone, 
Retinoids, D-glucarate, Steroidal Anti-
inflammatory agents 
Induce Differentiation Retinoids, Calcium, Sodium Butyrate 
         -Encourage Apoptosis DHEA, Fluasterone, Fenretinide, Sodium 
Butyrate, Curcumins, 2-methoxy-extradiol 
         -Detoxify Steroid Hormones D-glucarate, Aromatase Inhibitors, Anti-
estrogens such as Tamoxifen 
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C, and vitamin E appear to inhibit chemical carcinogenesis in a similar manner to the 
phenolic antioxidants by their effect on the metabolism of the carcinogen, their 
antioxidizing activity, and preventing the formation of carcinogens.  The mechanisms by 
which selenium inhibits chemically induced tumors may be related to its effect on the 
glutathione peroxidase since it is a cofactor for this enzyme [Walaszek 2004].   
The process of tumor promotion and progression involves a combination of 
several mechanisms.  Among anti-tumor promoting mechanisms, Table 1, the ones that 
are most promising include the following: inhibition of inflammation, inhibition of cell 
proliferation and hyperplasia; modulation of cell differentiation and apoptosis; 
scavenging of reactive oxygen species and preventing depletion of anti-oxidant defense 
systems; and enhancement of tumor promoter detoxification pathways [Walaszek 2004].  The 
natural and synthetic cancer preventive agents that exert their effects against tumor 
promotion usually inhibit one, more, or even all events involved in the tumor promotion 
process [Walaszek 2004].  It is unclear however, whether inhibition of one particular event 
involved in promotion by chemopreventive agents is sufficient to exert their maximum to 
complete anti-tumor promoting effects.   
 Natural compounds found in plant products may prevent carcinogenesis by 
interfering with the actions of mutagens, carcinogens, and tumor promoters.    These 
natural compounds are effective inhibitors of tumor initiation, promotion, and or 
progression. Their mechanism of action is related to their abilities to prevent critical 
carcinogen metabolism and to increase detoxification of carcinogens and tumor 
promoters.  The potential role of the detoxification system and the roles of d-glucaric acid 
have been studied [Hanausek 2003] . 
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 The potential role of a detoxification system and the roles of D-glucaric acid and 
β-glucuronidase in early detection and prevention of cancer have been investigated 
[Hanausek 2003].  β-Glucuronidase is one of many pro-carcinogenic enzymes.  D-glucaric acid 
is a natural, apparently nontoxic compound produced by some plants, especially in fruits 
and vegetables, and in small amounts by mammals, including humans.  D-glucaric acid 
an end product of d-glucuronic acid or its lactone leads to oxidation products that 
hydrolyze spontaneously in aqueous solution to give the potent beta-glucuronidase 
inhibitor, d-glucaro-1,4 lactone, noninhibitory d-glucaro 6,3 lactone, and d-glucaric acid, 
all of which are excreted in urine.  D-glucaric acid was identified as a normal constituent 
of urine and serum.  In fact, d-glucaric acid is a major serum organic acid.  However, 
significant differences in serum levels and urinary excretion of d-glucaric acid have been 
reported in healthy patients.  Since urinary excretion of d-glucaric acid increases 
following exposure to xenobiotics, it was suggested for use as an indirect indicator of 
hepatic microsomal enzyme induction by xenobiotic agents.  D-glucaric acid urinary 
excretion in cancer patients and tumor-bearing rats was found to be significantly lower 
than in healthy controls.  In mice with experimental tumors and in cancer patients, 
uninvolved liver had a lowered d-glucaric acid level [Hanausek 2003].  Cancer tissue itself 
lacked the d-glucaric acid synthesizing system. 
 The physiological function of D-glucaric acid is unclear.  Formation of D-
glucaro-1,4 lactone, and inhibitor of beta-glucuronidase , from one of the products of its 
hydrolytic action, could be regarded as a negative feedback mechanism.  The 
accumulation of free carcinogens, tumor promoters, and other toxins normally excreted 
as glucuronides may be aggravated not only by the elevated beta-glucoronidase activity 
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but also by the depressed synthesis of glucaric acid.  D-glucaro-1,4 lactone does not  
directly affect the uridine 5’-diphospho-glucuronosyltransferase activity.  However, by 
inhibiting beta-glucoronidase, it does enhance net glucuronidation.  Therefore, it has a 
potential for chemoprevention of cancer [Hanausek 2003].  There is now extensive evidence 
from short-term and long-term models for the possible control of different stages of 
carcinogenic process by the beta-glucoronidase inhibitor D-glucaro-1,4-lactone, and 
specifically by its precursors such as d-Glucaric acid salts (D-glucarates) [Walaszek 2004].  A 
phase I clinical trial was undertaken to begin to explore the potential role of D-glucaric 
acid in the prevention of lung cancer in tobacco smokers.  K-ras oncogene mutations 
were present in some of the smokers in the lung cancer study, but there was no evidence 
of K-ras oncogene mutations in non-smokers implying that K-ras mutations may be 
involved in the development of malignant tissues.  D-glucaric acid is thought to interfere 
in the K-ras pathway thereby preventing the conversion of benign cells to malignant ones. 
 Oral doses of glucaric acid were shown to inhibit beta-glucoronidase.  In current 
human studies, d-glucaric acid is administered in the form of calcium-d-glucarate.  The 
glucarate is ingested orally and the acidic environment of the digestive system converts 
the salt to the acid form.  The d-glucaric acid is then metabolized into 3 isomeric forms- 
d-glucaric acid, d-glucaro-1,4 lactone, and d-glucaro 6,3 lactone.  These compounds are 
absorbed through the lining of the gastrointestinal tract, enter the blood stream, are 
circulated throughout the body, and then excreted in the urine [Thorne 2002]. The implications 
of these findings are that K-ras mutations may be involved in the development of 
malignant tissues, and d-glucaric acid is thought to interfere with the K-ras pathway 
thereby preventing the conversion of benign cells to malignant ones. 
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Drug Delivery Systems 
 
 A therapeutic agent interacts with the body at one of three sites:  within the 
circulation or interstitial space, at membrane receptors on the surface of the cell, or at 
various sites of cellular machinery within the cell.  A wide variety of polymeric 
biomaterials are routinely used for delivering drugs to these sites [Ratner 2004].  The major 
advantage of developing systems that release drugs in a controlled manner is illustrated in 
Figure 1 which shows blood plasma levels following a single dose administration of a 
therapeutic agent.  When drugs are taken orally, the blood plasma concentration rapidly 
rises and then exponentially decays as the drug is metabolized and eliminated from the 
body [Ratner 2004].  The figure also shows drug concentrations above which the drug could 
be toxic or have adverse effects and below which it is not therapeutically effective.  The 
difference between these two levels is known as the therapeutic index. 
Increasing the size of the dose does increase the time during which the 
concentration of the drug is above the minimum effective concentration, however this can 
also increase the chances of approaching toxic blood plasma concentrations and side 
effects. Desired drug concentration can also be maintained by periodic doses, but this is 
inconvenient and usually is impeded by poor patient compliance.  For these reasons, there 
have been great interest in developing controlled-release formulations and devices that 
can maintain a desired blood plasma level for long periods of time without reaching a 
toxic level or dropping below the minimum effective level.  These systems are called 
“zero order” systems because they release the drug at a constant rate [Ratner 2004].
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Figure 1.   Changes in Drug Concentration as a Function of Time.
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Research to successfully formulate pharmaceuticals to extend the activity of 
therapeutic agents began as early as the 1940’s.  The first product to minimize the 
frequency between oral doses was Spansules ®.  This consisted of small drug spheres 
encapsulated with a soluble coating.  By varying the thickness of the coating, the capsule 
dissolution times were extended thus prolonging the action of one dose of the drug.  
Today, these types of formulations are now known as “sustained release” or “prolonged 
release” and most recently “controlled-delivery” capsules [Ratner 2004]. 
 The functionality of these types of sustained release systems greatly depends on 
the local in vivo environment which varies from patient to patient.  To reduce patient-to-
patient variability, a major effort to develop products capable of releasing drugs by 
predictable and reproducible delivery kinetics was begun in the late 1960’s.  Such devices 
are known as “controlled-release” devices.  There are four types of controlled release 
systems- Drug Diffusion, Water Penetration, Swelling, and Chemical [Ratner 2004]. 
  Drug Diffusion Controlled Release Systems 
 
 There are two fundamentally different devices where the rate of drug release is 
controlled by drug diffusion.  These are membrane-controlled devices and monolithic 
devices. In a membrane controlled system, the active agent is contained in a core or 
reservoir which is surrounded by a thin polymer membrane.  The release into the 
surrounding environment occurs by diffusion through the membrane.  The rate of 
diffusion through the membrane is a function of the polymer membrane usually the 
porosity, the thickness, or the chemical reactivity [Ratner 2004]. 
 When the membrane is not porous, diffusion can be described by Fick’s first law: 
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dx
dCmDJ −=    (1)    
Where J is the flux per unit area, in g/cm2s, Cm is the concentration of the agent in the 
membrane in g/cm3, dCm/dx is the concentration gradient, and D is the diffusion 
coefficient of the agent in the membrane in cm2/s [Ratner 2004]. 
 Because the concentration of the agent in the membrane cannot be readily 
determined, Equation 1 can be rewritten using partition coefficients which describe the 
ratio of the concentration of the agent in the membrane when it is at equilibrium with the 
concentration in the surrounding medium. 
l
CDKJ Δ=      (2)    
where ΔC is the difference in the concentration between the solutions on either side of the 
membrane, K is the partition coefficient, and l is the thickness of the membrane [Ratner 
2004]. 
 Reservoir devices, such as the adhesive patch illustrated below, can also be 
constructed with membranes that have well-defined pores that permeate through the 
membrane.   
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Figure 2.  Schematic of Reservoir Delivery Device. 
 
Diffusion in such micro-porous membranes occurs principally by diffusion through the 
liquid-filled pores where the composition of the liquid will control the overall transport 
flux across the membrane.  In this system, the flux is described by Equation 3 
l
CDKJ ⋅
Δ= τ
ε    (3)    
where ε is the volume fraction porosity, which is normalized as fractional area of pores 
per unit area of the membrane, and τ is the tortuosity the average length of pore channel 
through the membrane [Ratner 2004]. 
 One of the most important consequences of Equations 2 and 3 is that the flux J 
will remain constant provided that all parameters remain constant including that the 
membrane material does not change with time.  Another requirement for zero-order 
delivery is also that ΔC remain constant.  Also, the concentration of the agent in the core 
cannot change with time and the agent released from the device has to be rapidly 
removed, this is known as the sink condition.  Constant agent concentration in the core 
can be attained by dispersing the agent in a medium in which it has a very low solubility 
leading to a saturated drug concentration in the reservoir [Ratner 2004].  However, preventing 
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drug build up around the device is not always possible.  Agents having very low water 
solubility often deviate from zero-order kinetics because of “boundary layer effects.”  
 Another factor that impedes constant drug release is migration of the agent from 
the core into the membrane during storage.  When this happens and the device is then 
placed in the release medium, the initial drug release is more rapid than expected because 
the agent diffuses from the saturated membrane.  The release rate then slows down until 
the steady-state, zero-order, release rate is achieved [Ratner 2004].  This initial nonlinear 
release is known as the “burst effect.” 
 In a monolithic device the therapeutic agent is uniformly dispersed or dissolved in 
a polymer matrix and the release is controlled by diffusion of the drug from the matrix.  
The matrix is assumed to be inert, either non-swelling or fully swollen, and non-
degrading.  Mathematical treatment of this type of diffusion depends on the solubility of 
the agent in the polymer.  This model is dependent on one of two assumptions.  One, the 
agent is present below its solubility limit and is dissolved in the polymer. Two, the agent 
is present well above its solubility limit and is dispersed in the polymer [Ratner 2004]. 
 For an agent that is dissolved in the polymer, release can be calculated by two 
equations, known as early time approximation and late time approximation 
2
1
22 ⎥⎦
⎤⎢⎣
⎡
⋅⋅= tl
DM
dt
dM
x
t
π   (4)    
2
2
2 exp
8
l
Dt
l
DM
dt
dM xt π=   (5)    
 These equations predict rate of release from a slab of thickness l, where D is the 
diffusion coefficient, Mx is the total amount of agent dissolved in the polymer, and Mt is 
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the amount released at time t.  According to Equation 4, which is valid over about the 
first 60% of the release time, the rate decreases linearly with the square root of time.  
During the latter 40% of the release time the rate decays exponentially with time, as 
shown by Equation 5.  Plots of these two approximations are shown in Figure 3 [Ratner 2004]  
When the agent is dispersed as particles in the polymer, release kinetics can be calculated 
by the Higuchi equation for a planar slab model system. 
2
1
2
2 ⎥⎦
⎤⎢⎣
⎡=
t
CDCA
dt
dM ost   (6)    
where A is the slab area, Cs is the solubility of the agent in the matrix, and Co is the total 
concentration of dissolved and dispersed agent in the matrix.  In this particular case, 
release rate decreases as the square root of time over the major portion of the delivery 
time and deviates only after the concentration of the active agent remaining in the matrix 
falls below the saturation value Cs [Ratner 2004]. 
  Water Penetration Controlled Release Systems 
 
 Water Penetration Controlled Delivery Systems are systems where the drug 
release rate is controlled by the rate of water diffusion into the device.  The two types of 
water penetration controlled systems are Osmotic and Swelling Controlled Systems. 
 Osmotically controlled devices operate according to the Figure 4.  
In this device, an osmotic agent is contained within a rigid housing and is separated from 
the drug by a movable partition.  One wall of the rigid housing is a semipermeable 
membrane, and when the device is placed in aqueous environment water is osmotically 
drawn across the semipermeable membrane.  The resultant increase in volume within the 
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Figure 3.  Release Kinetics of a Monolithic Delivery Device. 
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Figure 4.  Schematic of Osmotically Controlled Delivery Device. 
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osmotic compartment exerts pressure on the partition which forces the agent out of the 
device through the delivery orifice [Ratner 2004]. 
The volume flux of water across the semipermeable membrane is given by: 
[ ]PL
l
A
dt
dV
p Δ−Δ= πσ      (7) 
where 
dt
dV  is the volume flux, Δπ and ΔP are, respectively the osmotic and 
hydrostaticpressure differences across the semipermeable membrane, Lp is the membrane 
mechanical permeability coefficient, σ is the reflection coefficient, approximately 1, and 
A and l are the membrane area and thickness respectively 
The mass rate of delivery 
dt
dM  of the agent is then given simply by 
C
dt
dV
dt
dM =    (8)    
 where C is the concentration of the agent in the solution that is pumped out of the  
orifice [Ratner 2004]. 
  Swelling Controlled Release Systems 
 
 In swelling controlled devices, the agent is dispersed in a hydrophilic polymer 
that is stiff or glassy in the dehydrated state and when placed in aqueous environment 
will swell and absorb the solvent from the environment.   Because diffusion of molecules 
in a glassy matrix is extremely slow, no significant release occurs while the polymer is in 
the glassy state.  However, when the material is placed in an aqueous environment, water 
will penetrate the matrix and as a consequence of swelling the drug diffuses out of the 
matrix and is released from the polymer [Ratner 2004]. 
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Figure 5.  Schematic of a Swelling Controlled Delivery Device. 
 
 The process shown schematically above (figure 5) is characterized by the 
movement of two fronts [Ratner 2004].   
B is a block of glassy polymer in the dehydrated state.  One front, the swelling 
interface (A), separates the glassy polymer from the swollen rubbery polymer and moves 
inward into the device at a velocity, v.  The other front, the polymer interface (C), moves 
outward as it swells, and separates the swollen polymer from the pure dissolution 
medium.  The polymer may go through a gel state as it swells.  In systems where the 
glassy polymer is non-crystalline and linear, dissolution takes place.  When the polymer 
is highly crystalline or crosslinked, no dissolution takes place and the swollen polymer 
remains as a hydrogel [Ratner 2004]. 
Chemically Controlled Release Systems 
 
 Chemically controlled delivery systems are divided into two categories:  
degradable reservoir and drug dispersed in a biodegradable matrix.  The degradable 
reservoir system contains the drug in the core of a solid implant covered by a 
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biodegradable membrane.  This delivery system is identical to the reservoir system 
except that the membrane surrounding the drug core is bioerodible or biodegradable.  
Such systems combine the advantage of long-term zero-order drug release with 
bioerodibility or biodegradability.  Because constancy of drug release requires that the 
diffusion coefficient D of the agent in the membrane remain constant, the bioerodible 
membrane must remain essentially unchanged over the duration of drug delivery.  
Typically, the bioerodible polymer and the drug are both hydrophobic. The membrane 
must remain intact while there is still drug in the core to prevent its abrupt release.  Thus, 
significant bioerosion cannot take place until drug delivery has been completed.  The 
second type of chemically controlled system is the most common because the drug is 
dispersed in a biodegradable matrix and release of the drug is determined by the rate of 
degradation of the polymer holding the drug in the matrix [Ratner 2004]. 
Biodegradation 
 
 The development of an implantable biodegradable drug delivery system is 
probably the most widely investigated application of degradable polymers because the 
device will eventually run out of drug or the need for the delivery will be eliminated once 
the disease has been treated [Ratner 2004].  One of the most important prerequisites for the 
successful use of a degradable polymer for any medical application is a thorough 
understanding of the way the device will degrade or erode and resorb from the implant 
site into the body.  The transformation of such an implant into water soluble materials is 
best described by the term bioerosion.  The bioerosion process of a solid polymeric 
implant is associated with macroscopic changes in the device’s mechanical properties 
such as swelling, deformation or structural disintegration, weight loss, and the eventual 
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depletion of the drug and loss of function.  Each of these properties represents distinct 
and often independent aspects of the complex bioerosion behavior of a specific polymer.  
It is important to note that the bioerosion of a solid device is not necessarily due to the 
chemical cleavage of the polymer backbone or the chemical cleavage of crosslinks or 
side chains [Ratner 2004].   
 Two distinct modes of bioerosion have been described in the literature, bulk 
erosion and surface erosion.  In bulk erosion, the rate of water penetration into the solid 
device exceeds the rate at which the polymer is transformed into water-soluble 
monomers.  Consequently, the uptake of water is followed by an erosion process that 
occurs throughout the entire volume of the solid device.  Because of the rapid penetration 
of water into the matrix of hydrophilic polymers, most of the currently available 
polymers will give rise to bulk eroding devices.  In a typical bulk erosion process, cracks 
and crevices will form throughout the device that may result in the device rapidly 
crumbling into pieces.  A good illustration for a typical bulk erosion process is the 
disintegration of an aspirin tablet that has been placed in water.  Depending on the 
specific application, the often uncontrollable tendency of bulk eroding devices to crumble 
is a disadvantage [Ratner 2004]. 
 In surface erosion, the bioerosion process is concentrated at the surface of the 
device.  Therefore, the device will become thinner with time but maintain its structural 
integrity throughout much of the erosion process.  In order to observe surface erosion, the 
polymer must be hydrophobic to prevent the rapid penetration of water into the interior of 
the device.  Because the drug will be released as the polymer swells, the rate at which the 
polymer degrades into water soluble monomers is slower than the rate of water 
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penetration into the device, so step one is to swell and release the drug then after the 
polymer has served its function to release the drug it then degrades.  Scanning electron 
microscopic evaluation of surface eroding devices has sometimes shown a sharp border 
between the eroding surface layer and the intact polymer in the core of the device. 
 Surface eroding devices have so far been obtained only from a small number of 
hydrophobic polymers containing hydrolytically degradable linkages in the backbone.  A 
possible exception to this general rule is enzymatic surface erosion.  The inability of 
enzymes to penetrate into the interior of a solid polymeric device may result in a 
concentrated enzyme-mediated surface erosion mechanism [Ratner 2004].   
 Although bioerosion can be caused by the solubilization of an intact polymer, 
chemical degradation of the polymer is usually the underlying cause for bioerosion of a 
solid polymeric device.  There are several distinct types of chemical degradation 
mechanisms that have been identified.  Chemical reactions can lead to cleavage of 
crosslinks between water-soluble polymer chains, to the cleavage of polymer side chains 
resulting in the formation of polar or charged groups, or to the cleavage of the polymer 
main chain backbone.  Combinations of these reactions are also possible.  For example, a 
cross-linked polymer may first be partially solubilized by the cleavage of crosslinks, 
followed by the cleavage of the backbone itself.  Water is the key to all of these 
degradation schemes.  Even enzymatic degradation occurs in aqueous environment [Ratner 
2004].  
 A hydrogel is a crosslinked polymeric system essentially forming one continuous 
network and this network has the ability to absorb solvent without damage to the 
network.  Hydrogels in pharmaceutical applications have become popular in recent years 
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because of their biocompatibility [Ratner 2004].  Pharmaceutical hydrogel systems include 
matrices that have a drug incorporated into them and are swollen to equilibrium.  There 
are two types of the solvent-activated matrix release devices: swellable and swelling-
controlled.  A system prepared by incorporating a drug into a hydrophilic polymer can be 
swollen when brought in contact with water or biological fluids, but this swelling process 
may or may not be the controlling mechanism for diffusional release.  Release is 
determined by the relative rates of the macromolecular relaxation of the polymer and 
drug diffusion from the gel [Ratner 2004]. 
 In swelling controlled release systems, the bioactive agent is dispersed into the 
polymer to form nonporous films, disks, or spheres and upon contact with an aqueous 
dissolution medium a distinct front or interface occurs where the water solvent front 
penetrates into the polymer and separates the solid polymer from the rubbery, gel-like, 
state of the material.  Under these conditions, the macromolecular relaxations of the 
polymer influence the diffusion mechanism of the drug through the rubbery state.  The 
swelling process proceeds toward equilibrium at a rate dependent on the water activity in 
the system and the structure of the polymer.  If the polymer is crosslinked or if it is of 
sufficiently high molecular weight so that chain entanglements can maintain structural 
integrity, the equilibrium state is a water swollen gel.  The equilibrium water content of 
such hydrogels can very from 30% to 90%.  If the dry hydrogel contains a water soluble 
drug, the drug is essentially immobile in the matrix, but begins to diffuse out as the 
polymer swells in the water solvent. Drug release then depends on two simultaneous rate 
processes: water migration into the device and drug diffusion outward through the 
swollen gel [Ratner 2004].    
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 Hydrogels are crosslinked polymeric structures formed by either covalent bonds 
produced by the simple reaction of one or more comonomers, physical crosslinks from 
entanglements, association bonds such as hydrogen bonds or strong van der Waals 
interactions between chains, or crystallites bringing together two or more 
macromolecular chains that are able to swell in water.  Hydrogels can be categorized by 
their method of preparation, ionic charge, or structural features.  Hydrogels can be 
homopolymer, copolymer, multipolymer, or interpenetrating polymeric networks 
depending on the method of preparation.  Homopolymer hydrogels are crosslinked 
networks of one type of hydrophilic monomer unit.   Copolymer hydrogels are produced 
by crosslinking two comonomer units.  Multipolymer hydrogels are produced from three 
or more comonomers that have been reacted together to form a network.  Interpenetrating 
networks are usually formed by producing the first network and then swelling that 
network in the other monomer.  The monomer then reacts to form a second network 
structure that is intertwined with the first network.  Because of monomer functionalities 
and chemical nature of the functional groups within the chains, charge effects can occur 
producing neutral, anionic, cationic, or ampholytic gels.  Crosslinked networks can have 
amorphous, semi-crystalline or complexed physical structures.  In amorphous hydrogels, 
the macromolecular chains are arranged randomly. Semicrystalline hydrogels have dense 
regions of ordered macromolecular chains, or crystallites, that are arranged randomly.    
Complexed structures are those formed by hydrogen bonds or chemical complexes of one 
monomer with another or of the chains of the network [Ratner 2004]. 
 The terms crosslink and junction or tie-point indicate the connection points of the 
polymer chains that make up the network.  Hydrogel forming crosslinks may be carbon 
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atoms but they are usually small chemical bridges with molecular weights much smaller 
than those of the polymer chains.  A crosslink may also be an association of 
macromolecular chains caused by van der Waals forces or an aggregate formed by 
hydrogen bonds [Ratner 2004].  Aggregates are masses of physically entangled or weakly 
bound polymer chains that serve as junction points in the formation of a 3 dimensional 
network. 
   Methods of preparation of the initial networks include chemical crosslinking, 
photopolymerization, or irradiative crosslinking.  Hydrogels are produced by swelling 
crosslinked structures in water or biological fluids.  Because during preparation hydrogels 
must be brought in contact with water to yield the final swollen network structure, their 
physical behavior is largely dependent on their equilibrium and dynamic swelling 
behavior.  Usually, a hydrophilic crosslinked network is placed in water, and because of 
the thermodynamic compatibility of the macromolecular chains interacting with the 
solvent molecules the network then expands to its swollen state [Ratner 2004]. 
 The Flory-Huggins theory can be used to determine thermodynamic values related 
to the mixing process.  Flory’s model describing the equilibrium of crosslinked polymer 
networks proposed that the degree to which a polymer network is able to swell is 
determined by the elastic retractive forces of the polymer chains and the thermodynamic 
compatibility of the polymer with the solvent molecules.  In terms of the free energy of 
the system, the total free energy change of the system upon swelling is described as 
mixelastic GGG Δ+Δ=Δ  (9)    
 26
In this equation, ΔG elastic is the contribution due to the elastic retractive forces and ΔG mix 
represents the thermodynamic compatibility of the polymer and the swelling agent, water 
[Ratner 2004]. 
 Upon differentiation of Equation 9 with respect to the water molecules in the 
system, an expression can be derived for the chemical potential change of water in terms 
of the elastic and mixing contributions due to swelling [Peppas, Biomaterials] 
mixelastic μμμμ Δ+Δ=− 0,11   (10)    
Here, µ1 is the chemical potential of water within the gel and µ1,0 is the chemical 
potential of pure water [Ratner 2004]. 
 At equilibrium, the chemical potentials of water inside and outside of the gel must 
be equal.  Therefore, the elastic and mixing contributions to the chemical potential will 
balance one another at equilibrium.  The chemical potential change upon mixing can be 
determined from the heat of mixing, and the entropy of mixing.  Using the Flory-Huggins 
theory, the chemical potential of mixing can be expressed as: 
( )( )2,21,2,221ln sssmix vvvRT χμ ++−=Δ   (11)    
Where χ1 is the polymer water interaction parameter, v2,s is the polymer volume fraction 
of the gel, T is absolute temperature, and R is the gas constant [Flory]. 
 This thermodynamic swelling contribution is counterbalanced by the retractive 
elastic contribution of the crosslinked structure.  The elastic contribution of the 
crosslinked structure is described by the rubber elasticity theory.  Equilibrium is defined 
when these two forces are equal in a given solvent and at a specific temperature.  The 
volume degree of swelling, Q, is the ratio of the actual volume of a sample in the swollen 
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state divided by its volume in the dry state, and can be calculated using Equation 12 [Ratner 
2004]. 
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 Determination of the swelling characteristics of hydrogels is important to their 
biomedical and pharmaceutical applications because the equilibrium degree of swelling 
influences the surface properties and surface mobility, the optical properties, the 
mechanical properties, and the solute diffusion coefficient through these hydrogels [Ratner 
2004].   
 The parameter that describes the basic structure of the hydrogel is the molecular 
weight between crosslinks, Mc.  This parameter defines the average molecular size 
between two consecutive junctions regardless of the nature of those junctions and can be 
calculated by Equation 13 [Ratner 2004] 
( ) ( )[ ]
⎟⎟⎠
⎞
⎜⎜⎝
⎛ −
++−−=
2
1ln21
,23
1
,2
2
,21,2,21
s
s
sssV
v
cc v
v
vvv
MM
χ
      (13)    
 The second parameter of importance in structural analysis of hydrogels is the 
crosslinking density, ρx, which is the number of crosslinks in the system and is described 
by Equation 14 
c
x Mv
1=ρ         (14)       
 In these equations, v is the specific volume of the polymer, the reciprocal of the 
amorphous density of the polymer, and Mn is the initial molecular weight of the 
uncrosslinked polymer [Ratner 2004]. 
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 The mechanical behavior of hydrogels is best understood using the theories of 
rubber elasticity and viscoelasticity.  These theories are based on time independent and 
time dependent recovery of the chain orientation structure.  By using theories to describe 
the mechanical behavior, it is possible to analyze the polymer structure and determine the 
effective molecular weight between crosslinks as well to gain insight about the number of 
elastically active chains and cyclization versus crosslinking tendencies.  In many 
instances it is not possible to test the hydrogel under the exact conditions in which the 
device is used, and for this reason it is of particular importance to use theories to 
extrapolate properties at these conditions [Anseth 1996]. 
 The dependence of mechanical properties on the chemical properties of the 
polymer corresponds to typical methods used to examine polymers in a material selection 
process:  the monomers used, the polymerization conditions, the crosslink density, the 
degree of swelling, and the type of medium in which the material is swollen.  There are 
advantages and disadvantages of varying each of these parameters with respect to the 
ultimate hydrogel mechanical properties.   
 Rubbers are materials that respond to stresses with nearly instantaneous and fully 
reversible deformation.  Whereas glasses can be reversibly stretched only up to ~1%, 
rubbers typically exhibit reversible behavior up to ~1000% elongation.  Normal rubbers 
are lightly crosslinked networks with a rather large free volume that allows them to 
respond to external stresses with a rapid rearrangement of the polymer segments.  In their 
swollen state, most hydrogels satisfy these criteria for a rubber.  When a hydrogel is in 
the region of rubber-like behavior, the mechanical behavior of the gel is dependent 
mainly on the architecture of the polymer network.  General characteristics of rubber 
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elastic behavior include high extensibility generated by low mechanical stress, complete 
recovery after removal of the deformation, and high extensibility and recovery that are 
driven by entropic rather than enthalpic changes [Anseth 1996]. 
 To derive relationships between the network characteristics and the mechanical 
stress-strain behavior, classical thermodynamics, statistical thermodynamics, and 
phenomenological approaches have been used to develop an equation of state for rubber 
elasticity [Anseth].  From classical thermodynamics, the equation of state for rubber 
elasticity may be expressed as  
    (15)   
 
Where f is the retractive force of the elastomer in response to a tensile force, U is the 
internal energy, L is the length, V is the volume, and T is the temperature.  For ideal 
rubber elastic behavior, the first term in Equation 15 is zero; bonds are not stretched with 
changes in L.  This behavior is not true for most other materials, such as metals, where 
changes in length cause internal energy driven retractive forces.  For elastomeric 
materials, an increase in length brings about a decrease in entropy because of changes in 
the end-to-end distances of the network chains.  The retractive force and entropy are 
related through the following Maxwell equation 
      (16) 
Figure 6  graphically depicts these quantities for the thermodynamic equation of state for 
rubber elasticity.   
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Figure 6.  Retractive Force as a Function of Temperature of an Elastic Network. 
 
 
Stress-strain analysis of the energetic and entropic contributions to the retractive force 
(Equation 15) indicates that entropy accounts for more than 90% of the stress.  Thus, the 
entropic model for rubbery elasticity is a reasonable approximation. 
 From statistical thermodynamics, the retractive force of an ideal elastomer may be 
expressed as  
  (17) 
Here, k is the Boltzmann constant, r is a certain end-to-end distance, and Ω (r,T) is the 
probability that the polymer chain with and end-to-end distance r at temperature T will 
adopt a certain conformation.  Equation 17 assumes that the internal energy contribution 
to the retractive force is constant or zero.  Only the entropy contributions to the retractive 
force are considered.  Evaluation of Equation 17 for a single chain leads to   
         (18)    
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where rf 2 is the end-to-end distance in the bulk state for linear chains. 
 If the analysis is expanded to n network chains, then  
          (19)   
Here ΔAel is the change in Helmholtz free energy caused by elastic deformation.  After 
the integration and assuming no volume change upon deformation, the statistical 
thermodynamic equation of state for rubber elasticity is obtained below [Anseth 1996]. 
           (20)   
Here, τ, is the shear stress per unit area, ρ is the density of the polymer, Mc is the number 
average molecular weight between crosslinks, and λ is the extension ratio.  The quantity, 
ro/rf, is the front factor and is the ratio of the end-to-end distance in a real network versus 
the end-to-end distance of isolated chains.  In the absence of knowledge concerning these 
values, the front factor is often approximated as 1. 
 From Equation 20, the elastic stress of a rubber under uniaxial extension is 
directly proportional to the number of network chains per unit volume (ρ/Mc).  This 
equation assumes that the network is ideal in that all chains are elastically active and 
contribute to the elastic stress.  Network imperfections such as cyclic structures, chain 
entanglements, and chain ends are not taken into account.  To correct for chain ends 
 (21) 
where Mn is the number average molecular weight of the linear polymer chains before 
crosslinking.  This correction becomes negligible when Mn>>Mc. 
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 From constitutive relationships, the shear modulus G is then 
 (22) 
and the force per unit area is 
 (23) 
Note the dependence of the shear modulus on Mc.  Also, the stress-strain behavior of 
rubbery elastic materials is nonlinear.  Figure 7 illustrates the typical experimental 
behavior, along with the statistical thermodynamic predictions.  
While the thermodynamic and statistical thermodynamic approaches describe 
observed rubber-elastic behavior at low extensions quite well, the equations are less 
applicable and invalid at higher elongations (λ>3). 
  
 
Figure 7.  Stress vs. Elongation Curves of an Elastic Network. 
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Equation 21 can be modified to fit the mechanical behavior of a swollen rubber  
 (24) 
where τs and λs are the shear stress and elongation measured in the swollen state.  Here, vr 
is the ratio of the unswollen volume to the swollen volume or the polymer volume 
fraction, and No is the effective number of crosslinks determined from 
 (25) 
Therefore, for a given hydrogel at a fixed temperature, a higher degree of swelling results 
in a reduction of the stress.  Alternatively, if the degree of crosslinking is increased the 
stress is increased. 
 At very high extension ratios, the thermodynamic equations of state are less 
satisfactory and phenomenological treatments are used.  The phenomenological approach 
does not consider the molecular structure of the gel and is concerned only with the 
observed macroscopic behavior of the system.  The fundamental issue is to develop an 
equation for the energy stored in the polymer.  The most general form of an equation for 
the work that is stored in the body of an isotropic material as strain energy, W, is a power 
series expression [Anseth 1996] 
 (26) 
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Here, I1,I2, and I3 are the strain invariants given by 
         (27)      
           (28)          
                     (29)     
 The Mooney-Rivlin equation, which is an expression describing uniaxial 
extension of an incompressible material, retains two of the terms in the series given in 
Equation 26.  The first is the lowest member of the series, i=1,j=0, and k=0, and the 
second term is i=0,j=1, and k=0.  For the case of uniaxial extension and letting C1=C100 
and C2=C010, one obtains the Mooney-Rivlin equation [Anseth 1996] 
   (30) 
The equation of state from statistical thermodynamic analysis given in Equation 21 
predicts that the quantity τ/λ-1/λ2 should be constant, whereas the Mooney-Rivlin 
equation is able to better predict the stress-strain behavior at higher elongations. 
 Equation 30 can be modified to describe the behavior of a swollen hydrogel, and 
this expression is given below [Anseth 1996] 
   (31) 
 The viscoelasticity theory considers the relationships between elasticity, flow, and 
molecular motion in polymeric materials.  While the mechanical behavior of all materials 
exhibit some degree of elasticity and flow, the size of polymer molecules often lead to a 
viscoelastic response.  The magnitude of the viscoelastic response is strongly dependent 
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on the nature of the imposed mechanical motion.  For example, the viscoelastic response 
is at a maximum when the time scale of the mechanical motion is on the time scale of the 
mechanical motion of the polymer.  In general, hydrogels are not simply elastic materials, 
but behave viscoelastically.  The time dependence of the applied stress or strain is as 
important as the magnitude in predicting the material’s mechanical response. 
 An applied mechanical stress or strain leads to a time dependence on the strain or 
stress as the segments of the polymer chains move.  This movement instigates an internal 
response that results in a time dependent recovery when the initial condition is removed.  
If the recovery is complete at long times, the behavior is termed viscoelastic.  If the 
recovery is incomplete, the behavior is called viscoelastic-viscoplastic.  In general, a 
polymer may have several viscoelastic processes each associated with a particular 
molecular motion in the material. 
 If a constant shear stress, is applied to a viscoelastic material the shear strain is 
observed to be time dependent as shown in Figure 8.  The ratio of the time dependent 
shear strain to the applied stress is defined as the creep compliance, J(t).  If J(t) is 
measured over long times, J(t) shows little time dependence at very short and very long 
times.  At very short times, the time scale of the mechanically induced stress is much 
shorter than the time scale for the molecular motions in the polymer. The system remains 
unrelaxed and the creep compliance is Ju, and when the material is completely relaxed the 
creep compliance is Jr.  Because it is easier to vary the experimental temperature than the 
frequency, it is common to present data as a series of isochronals, with each curve 
representing data obtained at a specific frequency.  If a number of isochronals are 
obtained, the linear viscoelastic region can be identified.  In the linear region, J(t) is  
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Figure 8.  Stress Strain Curves of an Elastic Material Under Constant Stress. 
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independent of the magnitude of the stress that is imposed.  For nonlinear-viscoelastic 
behavior, each value of the applied stress leads to a time-dependent strain which can only 
be determined by an experiment conducted at that stress. 
  A constant shear strain is applied and the time dependence of the stress required 
to maintain that strain is measured.  The experiment is illustrated in Figure 9.  The stress 
relaxation modulus, G(t), is defined as the stress-strain ratio at constant deformation.  As 
in the case of creep, several isochronals can be plotted to determine the range of linear 
stress relaxation behavior. Unlike creep, nonlinear behavior leads to slower stress 
relaxation, In certain regions, J(t) and G(t) have a nearly reciprocal relationship, 
especially at short times and for crosslinked systems at long times as well. 
Rheological analysis provides quantitative information on the viscoelastic 
properties of a material by measuring the mechanical response of a sample as it is 
deformed.  Generalized input and response curves are depicted in Figure 10. 
A common notation for sinusoidal tests is the complex dynamic modulus, G*, defined 
below 
 (32) 
Here, G’ is the real, also elastic or storage modulus and G’’ is the imaginary also viscous 
or loss modulus.  These definitions apply to testing in the shear mode where G refers to 
the shear modulus, σ’ to the shear stress, and γ’ to the shear strain.   
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Figure 9.  Stress Strain Curves of an Elastic Material Under Constant Strain. 
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Figure 10.  Viscolelastic Response of an Elastic Material. 
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Likewise, similar definitions can be applied for testing in the normal mode for the 
complex modulus and complex compliance.   
In the dynamic mode of testing, if the strain is a complex oscillatory function of 
time with maximum amplitude γm and frequency ω, then  
    (33)   
By analogy with the Maxwellian element of viscoelasticity is 
    (34)   
where θ is a characteristic time constant and is equal to η/G. 
Here, G has no physical meaning related to the dynamics of the polymer, but 
describes the modulus of the analogue.  The same is true of η, which has no physical 
meaning related to the viscosity dynamics of the polymer, but again describes the 
viscosity of the analogue.  Taking the derivative of the shear strain in Equation 33 and 
substituting into Equation 34, we can then solve the linear differential equation and the 
solution is given below [Anseth 1996] 
     (35)   
Or 
          (36)   
where the measured response of the shear stress is then shifted by a phase angle delta 
with a maximum amplitude σm.   
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Thus, by comparison of Equations 32 and 35 
               (37)   
and 
       (38)   
If we define the ratio of the loss to the storage modulus as the damping or dissipation 
factor, then 
      (39)   
The damping factor, tan delta, measures the ratio of the energy dissipated as heat to the 
maximum energy stored in the material during one cycle of oscillation.  Representative 
plots of the storage, loss, and damping factor are shown in Figure 11. 
 
 
Figure 11.  Loss and Storage Modulus as a Function of Temperature. 
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At low times or temperatures, the polymer is glassy and the storage modulus, G’, is in an 
unrelaxed state.  As the temperature is increased, the viscoelastic nature of the materials 
is seen and a transition region in G’ is observed.  At still higher temperatures, another 
plateau in G’ occurs as the polymer is now in a relaxed, rubbery state. In contrast, the loss 
modulus, G’’, goes through a maximum as the temperature is increased.  G’’ is a measure 
of the viscous contribution to the modulus.  The viscous contribution is at a maximum 
near the inflection point of the transition region in G’.  The characteristic shape of the 
damping factor versus temperature is also shown.  This curve provides one of the 
mechanical definitions for the glass transition temperature, α-relaxation.  The glass 
transition temperature is taken as the temperature at which the maximum in the damping 
factor curve is observed.  Other transitions associated with side chains or branches are 
also often observed as peaks.  The transition associated at the highest temperature is often 
termed the α-relaxation, while subsequent temperature transitions are labeled as β-
relaxations, etc. in order of descending temperature at which the transition occurs.  
Depending on the homogeneity of the network, the peak associated with the α-relaxation 
(Tg) can be quite broad [Anseth 1996]. 
Natural Polymers 
 
 Natural polymers offer the advantage of being very similar, often identical, to 
macromolecular substances which the biological environment is prepared to recognize 
and to deal with metabolically.  The problems of toxicity and stimulation of a chronic 
inflammatory reaction, as well as lack of recognition by cells, which are frequently 
provoked by many synthetic polymers, may thereby be suppressed.  Furthermore, the 
similarity to naturally occurring substances introduces the interesting capability of 
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designing biomaterials that function biologically at the molecular, rather than the 
macroscopic, level.  On the other hand, natural polymers are frequently quite 
immunogenic.  Because they are structurally much more complex than most synthetic 
polymers, their technological manipulation is quite a bit more elaborate.  On balance 
however these opposing factors have conspired to lead to a substantial number of 
biomaterials applications in which naturally occurring polymers, or their chemically 
modified versions, have provided unprecedented solutions. 
 An intriguing characteristic of natural polymers is their ability to be degraded by 
naturally occurring enzymes, a virtual guarantee that the implant will eventually be 
metabolized by physiological mechanisms.  This property, at first glance, may appear as a 
disadvantage since it detracts from the durability of the implant.  However, it has been 
used advantageously in biomaterials applications in which it is desired to deliver a 
specific function for a temporary period of time, following which the implant is expected 
to degrade completely and to be disposed of by largely normal metabolic processes.  It is 
possible to control the degradation rate of the implanted polymer by chemical 
crosslinking or other chemical modifications [Dumitriu 1996]. 
 Many natural polymers form three-dimensional networks.  These gels are usually 
stabilized by interchain interactions and have properties comparable to chemically 
crosslinked synthetic gels.  There are also numerous biomolecules and cell types that 
have been immobilized on and within hydrogels [Dumitriu 1996].   
 Two-thirds of the human body consists of water, and almost all known biological 
reactions occur in water. Water needs a container to act as a medium where chemical 
reactions can occur: nature invented two kinds of containers- cells and gels.  The ability 
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of polysaccharides to form a network structure, gel, even at low concentrations, 
constitutes one of their most important functional properties.  Recently, there is increased 
interest in starch gelation in the pharmaceutical field because of the need for three-
dimensional matrices with controlled release properties.  Gelation is the formation of a 
three-dimensional network structure and offers an effective means to increase a polymer 
system’s mechanical and chemical stability.  Polysaccharide mixtures occur naturally, 
and binary carbohydrate gels may be used as models for complex cellular structures and 
have been studied as models for the recognition step in certain host-pathogen interactions 
[Dumitriu 1996].   
 There are many structures that can be formed when two polysaccharides are 
mixed together and gelled.  These are dependent on the nature of the components, the rate 
and extent of demixing, and mechanism of gelation.  The simplest structure is obtained 
when component one forms a network and component two is just contained in component 
one.  At least three types of gel structure can occur if both polysaccharides contribute to 
the network.  One, the gel is an interpenetrating network where both polysaccharides 
associate independently to form separate networks but interlace with each other. Two, a 
phase-separated network occurs if some degree of demixing occurs prior to gelation and 
the two networks are spatially separated.  Three, a coupled network is formed if the two 
networks chemically bond to each other during gelation [Dumitriu 1996]. 
 The attachment of biologically active compounds to synthetic and natural 
polymers has been investigated as a means of improving the efficacy of drug controlled 
release devices through a constant but prolonged release of bioactive compounds with 
minimum side effects.  The controlled release of the bioactive compounds, which are 
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covalently coupled to the polymeric carrier via hydrolysable linkages, can be achieved by 
hydrolytic or enzymatic cleavage of the linking bonds [Dumitriu 1996]. 
 One of the main challenges in designing drug controlled release devices is to 
construct biocompatible carriers that are easily metabolized and eliminated, that do not 
adversely affect normal biological functions inside the human body, and are inexpensive 
for reducing health care costs.  A class of biomaterials that could be a potential candidate 
as the drug carrier is natural polymers, such as polysaccharides [Dumitriu 1996]. 
 Naturally occurring polysaccharides are one of the most abundant and diverse 
families of biopolymers, and are widely used in various fields.  Recently, considerable 
attention been focused on chemical modification of polysaccharides to be used as drug 
carriers for controlled release systems.  The repeating unit of polysaccharides may 
contain hydroxyl, carboxyl, amino, or sulfate functional groups, which provide the sites 
for the chemical modification of polysaccharides.  Starch, long-chain polymers of D-
glucose, is one of the most frequently used polysaccharides in the drug delivery system 
because of its biocompatibility, biodegradability, nontoxicity, and abundant sources 
[Dumitriu 1996]. 
Lenaerts et al. demonstrated that crosslinked high amylase starches have been 
used as excipients for the formation of controlled release solid dosage forms for the oral 
delivery of drugs.  Corn starch was highly crosslinked by using epichlorohydrin as a 
crosslinking agent.  Water transport kinetics and dimensional changes were studied in 
matrices placed in water at 37C by an image analysis technique.  The studies showed that 
a gel was formed very quickly at the polymer surface and water continually diffused into 
the core.  This process went on for several hours until the core turned into a gel and 
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equilibrium swelling was reached.  In vivo results with different drugs showed that high 
amylase crosslinked starches were highly versatile, had no food or drug interaction. 
    Remon et al. reported the production and characterization of thermally 
modified starch which might be used as hydrophilic matrices for oral drug delivery 
systems. Three native starches having a variety of amylase/amylopectin contents were 
pregelatinized by extrusion, drumdrying, and a controlled pregelatinization-spray-drying 
technique in order to produce cold-water-swellable starches.  Partial pregelatinized starch 
could only be produced by the controlled pregelatinization-spray-drying technique.  As 
regards the application as hydrogel matrices for controlled release tablets, promising 
results were seen for the extruded drum-dried starches containing medium to high amount 
of amylopectin. 
 Amylose and Amylopectin are the two components of naturally occurring starch.  
Amylose is a relatively linear homopolymer of glucose with a low molecular weight. 
Amylopectin is a highly branched homopolymer of glucose with a relatively high 
molecular weight.  Starch in both native and modified forms has been studied extensively 
over the past 50 years.  Crosslinked starch and starch networks have both the required 
biodegradability and a reasonable chemical and mechanical stability.  In its original form 
starch occurs as a granule made up of several layers of alternating crystalline and 
amorphous layers.  The regions of long-range crystallinity seem to involve crystallization 
of the amylopectin component of starch while the amylose component represents the 
amorphous phase of starch granules [Dumitriu 1996]. 
 A variety of physical techniques such as x-ray diffraction (XRD), small angle 
neutron scattering (SANS), small angle x-ray scattering (SAXS), and electron 
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microscopy (EM) have provided information on the nature of the amylopectin 
crystallites.  SANS, SAXS, and EM have shown periodicity occurring at 10nm which is 
thought to be the repeat distance between amorphous and crystalline regions of 
amylopectin [Dumitriu 1996]. 
 Opaque gels are obtained upon cooling of concentrated starch aqueous 
dispersions.  At this stage, elementary junction zones are locally established between the 
macromolecules.  These adopt locally a left-handed, parallel-stranded double helical 
conformation.  On aging, starch gels develop a B-type crystallinity from an aggregation 
process resulting in parallel arrays of the elementary junction zones.  A new three-
dimensional structure of B-starch is proposed in which the unit cell contains 12 glucose 
residues located in two left-handed, parallel-stranded double helices packed in parallel 
register, with 36 water molecules located between these helices.  It is now well 
established that amylose gels are poorly crystalline structures composed largely of an 
amorphous fraction [Dumitriu 1996]. 
 Leloup et al. have investigated the structural characteristics of amylose gels (2%-
8% w/vol) at different scales of organization.  Native gels have been studied by electron 
microscopy, mild acid hydrolysis, differential scanning calorimetry, and size-exclusion 
chromatography.  Amylose gels exhibit a macroporous structure, mesh size 100-1000nm, 
containing filaments 20+10 nm wide.  These filaments result from the association of 
segments of amylose chains which were oriented obliquely to the filament axis.  These 
amylose fragments are partially organized in a B-type crystalline array.  Upon acid or 
enzymatic treatments, the amorphous segments of amylose chains are hydrolyzed [Dumitriu 
1996].    
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 Amylopectin can have a very high molecular weight as large as 108 though 
measuring the molecular weight has been difficult due to the aggregation of the chains of 
the polymer in solution which can lead to an over-estimation of the size of the molecules. 
[Durrani and Donald 1995].  It has been recently observed that at sufficiently high concentrations 
solutions of amylopectin in water could gel when cooled to below room temperature.   
 Even though there are many investigations of biopolymer gels, there are relatively 
few studies of amylopectin.  Amylopectin is one of the two main components of starch.  
Amylopectin consists of D-glucopyranose monomers which are connected either through 
alpha-1-4 or alpha 1-6 glycosidic bonds [Durrani and Donald 1995].  The 1-4 bonds produce the 
linear backbone of the chain and the 1-6 bonds are the branch points off the main chain 
backbone.  Amylopectin is a high molecular weight natural polymer with non-random 
branches.  The branching of the polymer is extensive and responsible for the molecule’s 
large hydrodynamic volume and ability to gel at concentrations of 3% and above in 
aqueous solution.   The branching is non-random, and the architecture of the molecule is 
debated because of the influence of steric hindrance and the placement of inner and outer 
chains.  The most accurate molecular structure seems to be described by the cascade type 
branching theory with the amylopectin branches arranging themselves in clusters of 
tiered branches as illustrated in Figure 12 [Durrani and Donald 1995]. 
 Gelation is the crosslinking of many polymer chains into progressively larger 
branched polymers to an extent ultimately producing a single molecule spanning the 
entire system.  Starch gelatinization is the process by which solubilization, hydration, and 
swelling of starch molecules occurs.  As the dispersed starch is heated in solution, the 
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Figure 12.  Schematin of Amylopectin Structure. 
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 randomly coiled chains uncoil and become hydrolyzed then recoil upon cooling creating 
physical entanglements among neighboring chains [Whistler 1984].  
Hydrogen bonding is the second most important mechanism of starch gelation 
next to physical entanglement, and the solvent properties of water are solely responsible 
for the hydrogen bonding of the starch gels [Morawetz 1965].  In the Figure 13, oxygen is 
surrounded tetrahedrally by four hydrogen atoms- two with which it forms a covalent 
bond, and two belonging to neighboring water molecules to which it is hydrogen bonded.   
A hydrogen bond can form between two neighboring water molecules only if a 
hydrogen lies close to the line connecting their oxygen atoms.  This prevents the 
molecules from packing as efficiently as they would if their interactions were due solely 
to dispersion forces and dipole-dipole interactions [Morawetz 1965].   During the gelation of 
starch in water hydrogen bonding occurs around the perimeter of the starch helices as 
well as the within the alpha helix.  The alpha helix is capable of accommodating as many 
as 32 interstitial water molecules per turn of the alpha helix [Morawetz 1965].  Previous studies 
have shown that gelation of an amylopectin solution is accompanied by the development 
of crystallinity, deduced from the growth of diffraction peaks in x-ray diffraction 
patterns.  It is thought that an amylopectin gel is a network which is formed by junction 
points of ordered crystalline regions within the system of the amylopectin molecules.  
The gels are white and opaque, indicating that they consist of phase separated regions on 
a length scale of the order of the wavelength of visible light [Durrani and Donald 1995]. 
 The phenomenon of polymer immiscibility is well known and arises as a result of 
the generally unfavorable interactions between polymer species.  Even a small positive 
free energy of interaction between different polymer species can result in limited 
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Figure 13.  Schematic of Hydrogel Bonds in Water Molecules. 
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miscibility due to the small entropy gain on mixing these high-molecular weight species.  
The miscibility of polymers in solution decreases with increasing polymer concentration 
and is rare at high concentrations.  If the segregation factor is strong, demixing is 
predicted when the polymer chains start to become entangled about the coil-overlap 
threshold.  The phase behavior of these ternary systems polymer1 +polymer 2 + solvent 
is often strongly affected by polymer-solvent interactions.  Immiscibility is generally 
increased when the affinity of one polymer for the solvent is significantly different from 
that of the other.  Biopolymers also exhibit immiscibility, with perhaps the best known 
example being the gelatin-gum Arabic-water system.  Compared to synthetic polymer 
mixtures, there is relatively little information on the phase behavior of polysaccharide 
mixtures. 
 Starch occurs as a mixture of amylose and amylopectin which are organized into a 
semi-crystalline granule.  The behavior of aqueous solutions of starch is of interest 
because starch is processed by heating in the presence of water.  Whereas amylose is 
essentially a (1-4)alpha-D-glucan, amylopectin is a (1-4)alpha –D-glucan with an average 
of one in every 20-25 residues branched at position 6.  As these polymers are so 
chemically similar, it might be expected that immiscibility would only be observed at 
very high concentrations.  However, even moderately concentrated aqueous solutions of 
amylose and amylopectin exhibit immiscibility [Kalichevsky 1987]. 
 According to Kalichevsky’s work using mixtures of amylose and amylopectin of 
varying concentrations from pure amylose to pure amylopectin in a 10% total aqueous 
solution, the binodal phase diagram is not symmetric but is shifted towards the amylose-
rich phase.  This is consistent with the behavior predicted for a mixture containing 
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polymers of unequal molecular weight, the bimodal being displaced towards the polymer 
of lower molecular weight.  The tie lines between phases at equilibrium with each other 
slope up to the amylose rich phase, indicating that this phase has a higher affinity for the 
water solvent [Kalichevsky 1987]. 
 The investigation of the phase behavior of amylose and amylopectin, using 
amylose of different molecular weights and structures as well as different temperatures 
(70C-90C), shows that these factors do not strongly affect the unfavorable interaction 
between these polysaccharides which gives rise to the phase separation.  It is noted that 
the differences in molecular weight between the amylose samples used are small relative 
to the large differences between amylose and amylopectin.  From the observation that 
phase separation only occurs at concentrations well above C*, minimum polymer 
concentration to induce phase separation, it is apparent that the segregation factor is not 
very strong.  It has been observed that immiscibility becomes greater with increasing 
molecular weight, so the high molecular weights of these polysaccharides, especially the 
amylopectin, encourage phase separation.  The incompatibility of the linear and branched 
polymers of starch in aqueous solution has important implications.  Incompatibility may 
also affect the types of interactions which can occur and should be considered as part of 
the gelatinization behavior of starch on heating in water [Kalichevsky 1987]. 
Crosslinking of Starch 
 
 Chemical crosslinking is defined as a direct reaction of a linear or branched 
polymer with at least one difunctional, small molecular weight, crosslinking agent.  The 
purpose of this agent is to link two larger molecular weight chains through its di- or 
multifunctional reactive chemical groups [Ratner 2004].  Crosslinking agents can be added to 
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a polymer solution after the polymer has been produced, and the reactive species of the 
agents will react with the polymer chains forming a chemically crosslinked system. (See 
Figure 14.) 
Copolymerization crosslinking is a reaction between a solution of one or more 
types of monomers including one multifunctional monomer that is present in relatively 
small quantities where the polymerization of the polymer and the chemical crosslinking 
of the system occurs in one step.  Another method is the combination of monomer and 
linear polymeric chains that are crosslinked by means of an interlinking agent [Ratner 2004]. 
 Crosslinking is one of the oldest methods for the chemical modification of 
polymers.  Various degrees of crosslinking can be introduced into polysaccharides for the 
purpose of generating larger molecular aggregates with enhanced viscosity profiles, or for 
the preparation of insoluble products with a wide range of swelling characteristics [Dumitriu 
1996].  Some of the most common crosslinking agents include bi- and tri- functional 
reagents, such as epichlorohydrin, bisepoxides, dihalogenated reagents, glutaraldehyde, 
acetaldehyde, formaldehyde, maleic and oxalic acid, dimethylurea, polyacrolein, 
diisocyanates, divinyl sulfate, ceric redox systems, and s-triazine.  There are also factors 
to be considered when chemically crosslinking such as the extent of the reaction and the 
number and character of side reactions.  An important parameter often used for 
identification of the final crosslinked structure is the cross linking ratio, CR, which is 
defined as the ratio of moles of crosslinking agent to the moles of polymer repeating units  
[Dumitriu 1996].  For bifunctional crosslinking agents, the number average molecular weight 
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Figure 14.  Steps in Formation of a Network of Polymer and Crosslinker. 
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 between crosslinks, Mc, may be determined by the relation  
CR
MM rc 2
=    (40)    
 where Mr is the molecular weight of the repeating unit. 
 The addition of a chemical crosslinker is important in order to improve both the 
integrity of the gel and also the predictability of mechanical properties.  Starch gels alone 
are inconsistent mechanically because of the extent of phase separation, formation of 
aggregates, and induced crystallinity of the system.  One aspect of biopolymer gelation 
which has been addressed by many authors is the relationship between gel modulus and 
concentration.  This relationship tests network theories which relate the molecular 
structure of the gel to the most obvious macroscopic aspect of the gel, the mechanical 
properties [Durrani and Donald 1995].   
 Crosslinked High Amylose Starch (CLHAS) was introduced a few years ago as 
the controlled release device, Contramid®.  Contramid® is a gel of starch crosslinked 
with epichlorohydrin.  It swells in water to form an elastic gel and the ability to regulate 
the swelling and thus regulate drug release in aqueous media as a function of crosslinking 
density makes this hydrogel particularly suitable for pharmaceutical applications.  The 
permeability of solutes across the hydrogel barrier, a dynamic state throughout the 
polymer device, depends on the texture of the hydrogel.  For instance, the texture of the 
helices of a starch hydrogel will effect the diffusion of solutes differently than a network 
that is made up of linear chains, and for the same reason polymer hydrophilicity and 
crystallinity play an important role in drug release.  Appropriate resistance of swollen 
tablets and good control of the drug release were only obtained for CLHAS with 
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moderate crosslinking degrees.  Higher degrees of crosslinking generated a sharp 
decrease in the release time and under certain conditions can even afford disintegrant 
properties for CLHAS.  The non-monotonic variation of the drug release time with 
crosslink density is a particular characteristic of the CLHAS matrix that differs from 
those of other classical polymeric matrices for which increasing the crosslink density 
leads to longer release times.  This behavior of CLHAS was ascribed to the particular 
structure of the matrix where, in the case of low crosslink density, covalent linkages, 
interchain hydrogen bonds, and water-promoted hydrogen associations stablilize the 
network thus controlling the access of water into the matrix.  Aspects of the water uptake 
as a function of crosslink density and its role in the release behavior of CLHAS tablets 
have been reported.   
 The native starch granule is heterogeneous both chemically, amylose and 
amylopectin, and physically, crystalline and amorphous regions.  The presence or 
absence of crystalline order is often a basic underlying starch properties.  Depending on 
their origins, various types of native starches present specific morphologies giving 
distinctive X-ray powder patterns termed type A, B, or C polymorphs.  The sharpness of 
the X-ray diffraction pattern of starch granules depends on their water content, the B type 
being more sensitive to hydration than the A-type starch. 
 For a better understanding of the role of crystallinity in release control, Ispas-
Szabo et al studied a series of powders, tablets, and films of high amylose starch with 
varying degrees of crosslinking.  When the crosslink density changes, the morphology of 
powder, tablet, or film also changes.  The variation of X-ray diffractograms as a function 
of crosslink density for powders and tablets was described.  They propose that the 
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compression of powders leads to molecular rearrangements and possibly to more 
extended hydrogen association.  When the powders are compressed, they believe that the 
aggregates of the polysaccharide chains come closer together, and their ability to resist an 
external force is related to the new molecular structure.  There is data that crushing 
strength of CLHAS tablets has been shown to depend on the crosslink density. 
 The presence of water and its influence on solid carbohydrate structure is often 
reflected in their spectra.  FTIR studies have correlated peaks at 1646 and in the 1300-
800 range as a region sensitive to the structure of the polysaccharides.  These 
investigators made films of CLHAS with varying crosslink densities and correlated the 
spectral shifts with the molecular conformational transitions from B- to V- type helix 
structure that was later confirmed by X-ray diffraction.  The x-ray and FTIR analysis 
correlated with dissolution kinetics and mechanical hardness of the dry tablets can 
generate interesting information on the structure-properties relationship in CLHAS 
matrices. 
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II. Chemistry 
  Formation of Crosslinked Network 
 
Starch 
 
 Polysaccharides are compounds made up of many hundreds or even thousands of 
monosaccharide units per molecule.  As in disaccharides, these units are held together by 
glycoside linkages, which can be broken by hydrolysis.  Polysaccharides are naturally 
occurring polymers, which can be considered as derived from aldoses or ketoses by 
polymerization with loss of water.  A polysaccharide has the general formula (C6H12O5)n 
.   By far the most important polysaccharides are cellulose and starch. Both are 
produced in plants from carbon dioxide and water by the process of photosynthesis, and 
both are made up of D-(+)-glucose units.  Cellulose is the chief structural materials of 
plants, giving the plants rigidity and form.  It is probably the most widespread organic 
material known. Starch makes up the reserve food supply of plants and occurs chiefly in 
seeds.  It is more water-soluble than cellulose, more easily hydrolyzed, and hence more 
readily digested [Morrison and Boyd 1983]. 
 Starch occurs as granules whose size and shape are characteristic of the plant 
from which the starch is obtained.  When intact, starch granules are insoluble in cold 
water; if the outer membrane has been broken by grinding, the granules swell in cold 
water and form a gel.  When the intact granule is treated with warm water, a soluble 
portion of the starch diffuses through the granule wall; in hot water the granules swell to 
such an extent that they burst [Morrison and Boyd 1983]. 
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Figure 15. Amylose 
 
  In general, starch contains about 20% of a water-soluble fraction called amylose, 
and 80% of a water-insoluble fraction called amylopectin.  These two fractions appear to 
correspond to different carbohydrates of high molecular weight and formula (C6H12O5)n.   
Upon treatment with acid or under the influence of enzymes, the components of starch 
are hydrolyzed progressively to dextrin, a mixture of low molecular weight 
polysaccharides, (+) maltose, and finally to D-(+)-glucose.  Both amylose and 
amylopectin are made up of D-(+)-glucose units, but differ in molecular size and shape as 
discussed previously. 
 The only disaccharide that is obtained by the hydrolysis of amylose is (+)-
maltose, and D-(+)-glucose is the only monosaccharide.  To account for this, it has been 
proposed that amylose is made up of chains of many D-(+)-glucose units, each unit 
joined by an alpha-glycosidic linkage to C-4 of the next one [Morrison and Boyd 1983].  
Amylose, as shown in Figure 15, is made up of long chains each containing 1000 or more 
D-glucose units joined together by alpha-linkages and there is little or no branching of the 
chain. 
 Like amylose, amylopectin is made up of chains of D-glucose units, each unit 
joined by an alpha-glycoside linkage to C-4 of the next one as shown in Figure 16.  
However, its structure is more complex than that of amylose.  Molecular weights  
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Figure 16.  Amylopectin. 
 
determined by physical methods show that there are up to a million D-glucose units per 
molecule.  Amylopectin has a highly branched structure consisting of several hundred 
short chains of about 20-25 D-glucose units each.  One end of each of these chains is 
joined through a C-1 to a C-6 on the next chain [Morrison and Boyd 1983]. 
Ester Linkage 
 
 An ester linkage is the product of a condensation reaction of an acid and an 
alcohol.  Condensation is a chemical reaction in which two molecules join together and in 
the process eliminate a smaller molecule.  In the reaction of the acid and the alcohol the  
–OH groups of each react and eliminate a water molecule creating a –COO-C- bond.  
Ester linkages degrade hydrolytically.  The most common esters are formed from 
carboxylic acids [Morrison and Boyd 1983]. 
 Dicarboxylic acids have two reactive –COOH ends.  Because of the two charged 
ends, the reactivity of one end may affect the other resulting in different pKa values of 
each carboxyl group.  This however is dependent on the length of the molecule, the 
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shorter the molecule the larger the difference in the reactivities of the ends.  The chemical 
properties of di-acids are usually comparable to monocarboxylic acids [Morrison and Boyd 1983]. 
Glucaric Acid 
 
 D-Glucaric Acid is a dicarboxylic acid derived from glucose [Morrison and Boyd 1983].   
Figure 17 lists various glucose derivatives including glucaric acid and sorbitol.  
D-glucaric acid is thought to take one of four conformations when dissolved in 
aqueous solution.  All of these conformations seem to be in dynamic equilibrium with 
each other.  D-glucaric acid has a linear conformation with a carboxyl group at each end.  
Two of the other conformations are a 1,4 lactone and a 6,3 lactone.  The fourth 
conformation is that of a dilactone.   
D-glucaric Acid, D-glucaro-1,4-lactone, D-glucaro-6,3-lactone, and d-glucaro-
1,4:6,3 dilactone are compounds of significant biological interest [Horton 1982].  (See Figure 
18.) They are normal metabolites involved in the metabolism of d-glucuronic acid in 
mammals;  d-glucaro 1,4, lactone is a powerful, competitive and highly specific inhibitor 
of beta-d-glucosiduronase; and the dilactone is a precursor of the 1,4 lactone.  It is 
thought that the production of the 1,4 lactone from d-glucuronic acid can modify beta-d-
glucosiduronase in the body.  The 1,4 lactone has been considered as a potential drug for 
treating diseases in which it is suspected that there may be a disorder of d-glucuronic acid 
metabolism [Horton 1982].  The 1,4 lactone and the dilactone have been successfully tested in 
the treatment of rheumatoid arthritis.  These compounds also have anticoagulant 
properties and show some promise in lysosome stabilizing activity.   
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Figure 17.  Derivatives of Glucose. 
 
 
Figure 18.  Conformations of D-glucaric Acid in Aqueous Solution. 
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III. Materials and Methods  
Materials 
 
 Amylose, amylopectin, and D-saccharic acid potassium salt were all purchased 
from Sigma Aldrich (St. Louis, MO, USA). 
Synthesis 
 
 The starch gel was chemically crosslinked by condensation of the –OH groups of 
both amylose and amylopectin with the acid ends of the glucaric acid to form two ester 
linkages.  The crosslinked starch gels were synthesized by first dissolving glucaric acid 
potassium salt in deionized water.  Amylopectin dissolves only in cold water solutions 
while amylose dissolves only in hot water solutions, so each glucaric acid solution was 
allowed to cool to room temperature before adding the amylopectin powder and then the 
solution was heated before adding the amylose.  All solutions were constantly stirred to 
prevent sedimentation.  The amylose aggregates instantly if the water temperature is too 
low limiting the diffusion of water into the system, but the amylopectin will gel when the 
solution reaches approximately 75C.   The amylopectin glucaric acid solution was heated 
to approximately 55C before the amylose powder is incorporated into the solution.  The 
crosslinked starch solution was then heated until the viscosity of the system increases 
indicating the formation of the gel.  The gel was then removed from the heat source and 
allowed to cool to room temperature.  The synthesized samples are white, opaque, highly 
viscous, rubber-like gels.   
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Characterization of Crosslinked Gel 
 RAMAN 
 
 Raman Spectroscopy defines chemical bonds of a sample by taking advantage of 
the polarizability of the compound within the sample.  Raman was performed at room 
temperature on freeze dried samples. 
Rheology  
 
  Rheology is the study of the deformation and flow of matter. These properties are 
based on the micro- or nanostructure of the material including the molecular weight and 
structure of polymers in solution or the particle size distribution in a solid suspension.  To 
measure the mechanical properties, a viscous solution is placed between the parallel 
plates and a pressure transducer measures changes in torque as one plate is turned while 
the other plate is held stationary [Morrison 2001].  The force required to turn the plate is 
converted into mechanical data of the material, usually the elastic modulus. For these 
experiments, the samples were prepared before testing and the gels were placed between 
the plates and compressed to 1mm.  The edges were coated with mineral oil to prevent 
water loss.  All frequency sweep tests were performed at constant temperature, constant 
0.1% strain, and within a frequency range of 0.1-100 radians per second. 
Degradation 
 
 For the degradation experiments, the gel samples were placed in vials of the same 
culture media used in the cell study experiments described later, they were observed at 
room temperature over a period of several days, and the pH change of each solution was 
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checked periodically to observe the amount of dissociated di-acid that had been released 
from the system. 
Cell Studies 
 
 Preliminary studies of the effects of glucaric acid and glucaric acid crosslinked 
starch gels are complete.  These studies were performed in in vitro cultures of the U2OS 
cell line.  The U2OS cell line are human osteosarcoma cells.  Two types of experiments 
were performed:  cell proliferation assay and colony formation assay.  The growth assay 
is to test the ability of the carcinoma cells to reproduce and multiply in the presence of 
the gel.  The colony formation test is to prove that the carcinoma cells are mobile, and 
that the glucaric acid drug is not preventing the cells from forming growth colonies or in 
a sense recruiting surrounding carcinomas to form tumors. 
 The cells were plated and allowed to rest for 24 hours before introduction of the 
crosslinked gel.  The gel was prepared in the sterile environment of the tissue culture lab.  
The gel was incorporated into the cell culture media in swollen form. 
Colony Forming Unit Assay (CFU): 
 
 Cell lines were removed from liquid nitrogen and seeded onto 60 mm plates with 
media (DMEM, 15% FBS, 10 units of PenStrep) and then passage on a three-day/four-
day cycle. These cells were then split and 1,000 cells were seeded onto small plates. 
Varying concentrations of crosslinker were added to the media, and the cultures were 
allowed to grow for a period of 8 days.  After this growth period, the media was removed 
from each plate, rinsed with PBS, and 100% methanol was added to each plate to fix the 
cells for nine minutes. After fixing the cells, Giemsa stain (1.25 ml Giemsa stain, 1.5 ml 
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100% Methanol, QS to 50 ml) was added to cover the cells and allowed to incubate for 9 
minutes. After this incubation, the stain was removed and each plate was rinsed twice 
with distilled water to remove any excess stain remaining in the plate.  
Cell Proliferation Assay: 
 
 Cell lines were removed from liquid nitrogen storage and plated on 60 mm culture 
plates in media (DMEM, 15% FBS, 10 units of PenStrep).  At 90% confluence, cell were 
trypsinized, and re-plated, onto a 100 mm plate, and allowed to grow to 80% confluence. 
Once confluent, these plates are then trypsinized and counted (to count the cells, 50 µl of 
the collected cell suspension was added to 100 µl of PBS/EDTA and from that mixture 
50 µl of the solution was placed onto a hemocytometer and the four blocks counted, 
divided by four and multiplied first by the dilution factor and then by 10,000 to get the 
number of cells per milliliter of cell suspension) and 250,000 cells are seeded onto 
culture plates and allowed to grow for one day. On day two the crosslinked gel was added 
to the media.  The cells were counted daily for a period of 5 days after the addition of the 
gel.  Various crosslink concentrations were tested. 
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IV.  Results and Discussion 
Sample Nomenclature 
 
 Many different gels were investigated including amylopectin, amylose, 
composites of these two, and crosslinked composites with varying glucaric acid 
concentrations.  In the following data amylose is abbreviated as S, amylopectin as P, and 
glucaric acid as GA.  Numbers associated with these abbreviations are concentrations 
(wt/v %) of the components.  A list of sample nomenclature is presented in Table 2.  The 
gels were made in approximately 10mL batches so that multiple parallel plate 
experiments could be performed on the same sample. 
Raman Spectroscopy 
 
 The formation of the ester linkage due to the condensation reaction of the 
carboxylic groups of the glucaric acid with the hydroxyl groups of the starch, amylose 
and amylopectin was followed using Raman Spectroscopy.  The Raman spectra shows 
the presence of ester linkages upon addition of glucaric acid. 
Figure 19 tabulates literature peak ranges for specific chemical bonds in 
comparison with the peaks measured from the glucaric acid, the crosslinked gel, and the 
starch samples.  From this data, it is confirmed that ester linkages are present at 875, 975, 
and 1040 and shifts occur at 289, 406,550,830, 935, 976, 1055, 1220, 1265, 1445 with the 
addition of glucaric acid.  The presence of the ester linkage in the Raman Spectra of the 
crosslinked gel is conclusive proof that the di-carboxylic acid has chemically bonded to 
the starch. 
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Table 2.  Sample Nomenclature 
Abbreviation Definition 
5S_1 
5S_2 
5S_3 
5% (wt/v) Amylose Gel in water.  3 Runs 
from the same sample. 
10S_1 
10S_2 
10S_3 
10% (wt/v) Amylose Gels in water.  3 Runs 
from the same sample 
20P_1 
20P_2 
20P_3 
20% (wt/v) Amylopectin Gel in water.  3 
Runs from the same sample. 
5S5P_1 
5S5P_2 
5S5P_3 
5% (wt/v) Amylose with 5% (wt/v) 
Amylopectin Gel in water.  3 Runs from 
the same sample. 
5S10GA_1 
5S10GA_2 
5S10GA_3 
5% (wt/v) Amylose crosslinked with 10% 
(wt/v) Glucaric Acid Gel in water.  3 Runs 
from the same sample. 
20P10GA_1 
20P10GA_2 
20P10GA_3 
20% (wt/v) Amylopectin crosslinked with 
10% (wt/v) Glucaric Acid Gel in water.  3 
Runs of the same sample. 
5S5P5GA_1 
5S5P5GA_2 
5S5P5GA_3 
5% (wt/v) Amylose with 5% (wt/v) 
Amylopectin crosslinked with 5% (wt/v) 
Glucaric Acid Gel in water.  3 Runs from 
the same sample. 
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Figure 19. Raman Peaks Comparing Crosslinked Starch to Uncrosslinked Starch. 
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Rheology 
 
The changes in viscosity and modulus as a function of frequency for amylose, 
amylopectin, and crosslinked gels are presented in Figure 19.  The rheological data shows 
that the viscosity of the gels ranges from 1000 Pa to 100,000Pa at 0.1 (1/s) frequency 
depending on monomer components and concentrations.   
The storage modulus determined from the parallel plate rheological data shows 
conclusive evidence of increase for starch gels synthesized with the addition of glucaric 
acid as a chemical crosslinker.  Although not shown here, increasing concentrations of 
chemical crosslinker have a direct effect on storage modulus. However, this data is 
affected by the inhomogeneity of starch gels.  There is measurable scatter in gel storage 
modulus even within the same sample because the gels are inhomogeneous due to the 
phase separation behavior of the amylose and amylopectin components.  The overall 
trend illustrated in Figure 20 shows amylopectin gels with the lowest modulus, composite 
amylose and amylopectin gels in the middle, and amylose gels with the highest modulus.   
There were significant increases in modulus of crosslinked gels versus 
uncrosslinked gels as shown in Figures 21-25 The storage modulus of gels comparing 
single component, composite, and crosslinked composite also shows increases in 
modulus with addition of the glucaric acid chemical crosslinker.  Figure 24 is a plot of 
the individual runs and Figure 25  is a plot of the average values. 
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Figure 20.  Viscosity Data of Gels of Varying Compositions. 
Viscosity Data of Gels of varying compositions. 
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Figure 21.  Storage Modulus of Amylose Gels
Storage Modulus of 5% Amylose Gels, Crosslinked vs. Uncrosslinked 
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Figure 22.  Storage Modulus of Amylopectin Gels. 
Storage Modulus of 20% Amylopectin Gels, Crosslinked vs. 
Uncrosslinked
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Figure 23.  Storage Modulus of Composite Gels. 
Storage Modulus of Composite Starch Gel Crosslinked vs. Uncrosslinked 
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Figure 24.  Storage Modulus of Composite Gels. 
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Figure 25.  Storage Modulus of Composite Gels.
Storage Modulus Data of 5% Amylose, 5%Amylose with 5% Amylopectin, and
5%Amylose with 5% Amylopectin crosslinked with 5% Glucaric Acid  
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 The storage modulus data relates to Equations 40 for bifunctional crosslinking 
agents, the number average molecular weight between crosslinks, Mc, may be determined 
by the relation  
CR
MM rc 2
=
     (40)   
 
 
which is the ratio of molecular repeat units to twice the crosslink ratio.  This crosslink 
ratio is determined by the number of reacted crosslinking monomers which would be 
directly related to the concentration of crosslinker in the gel.  The increase in crosslinking 
of the system would decrease the average molecular weight between crosslinks of the 
network, and from Equation 22 
 
(22)    
 
 
the Elastic Modulus, G, is inversely related to the molecular weight between crosslinks.  
So, as the number of crosslinks increases, the average molecular weight between 
crosslinks decreases, and the modulus of the system increases. From these relationships, 
the increase in modulus between crosslinked and uncrosslinked gels is due to the 
chemical bonds formed by the crosslinker of the system.  
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Degradation 
 
 A schematic of the crosslinked starch gel is illustrated in Figure 26.  In the 
illustration the groups of helical chains represent the physically entangled starch chains 
the for aggregates.  The black lines are the exposed starch chains connected the 
aggregates and forming the network.  The blue lines are the glucaric acid crosslinks.  The 
crosslinks are illustrated both within the aggregates and between aggregates.  It is 
assumed that the glucaric acid reacts with the –OH groups on the outside of the starch 
helices but it has not yet been determined if the di-acid reacts before or after the 
formation of the starch aggregates during synthesis. If the chemical crosslinking occurs 
after the formation of the aggregates, then the bonds formed by the di-acid will reinforce 
the network formed by the aggregates.  If the chemical crosslinking occurs before the 
formation of aggregates, then the aggregates themselves are chemically crosslinked.  
From the data collected in this work, it is believed that the chemical crosslinking occurs 
simultaneously and that there are both crosslinked aggregates and di-acid crosslinks 
reinforcing the network. 
The degradation of the gel appears to occur in two stages.  Because the gels are 
made of aggregates, physically entangled starch molecular chains that serve as junction 
points of the network, the first stage of degradation is the hydrolytic degradation of the 
exposed chains holding the aggregated starch chains together.  The aggregates dissolve in 
the second stage of degradation because it takes more time for the water to diffuse into 
the physically entangled mass.  So, after the first stage of degradation, the network is 
broken and the aggregates are free to behave more like particles and precipitate out of 
solution.  
 80
 
Figure 26.  Schematic of Crosslinked Starch Hydrogel. 
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Visual observation reveals the un-degraded gel is a single mass with a 3-
dimensional structure whereas the degraded gel appears to be particles that have 
precipitated out of solution and clung to the sides as well as settled to the bottom of the 
beaker.  Figure 27 is the un-degraded gel and Figure 28 is after the gel has been 
submerged in cell culture media for 5 days.    
 Figure 29 is of degraded gels beginning with the uncrosslinked starch, 0.25% 
crosslinked starch, 0.5% crosslinked starch, and 5% crosslinked starch after 5 days in 
fetal bovine serum.  From these pictures, not only is there obvious sedimentation of the 
aggregates in most of the gels, but there is also noticeable differences in the color of the 
solutions.  A pH indicator is added to the culture media and turns from red to yellow 
when the pH changes from neutral to acidic. 
All of the solutions in Figure 29 were red in color when the gel was added to the 
media.  The 5% solution changed to yellow within 24 hours.  The 0.5% solution changed 
steadily over the 5 day span.  The control and 0.25% samples did not change.  From these 
images, it is not only evident that the gel is degrading, but in the 5% solution there is 
unreacted glucaric acid monomer present within the matrix hence the immediate color 
change.  The evidence of the unreacted monomer is the early change in pH that only 
occurs in the 5% sample.  The steady change in color in the 0.5% solution and the 
precipitation of aggregates implies that there is a steady release of acid into solution first 
by diffusion of the unreacted monomer and secondly by the hydrolytically degradation of 
the chemical bonds formed by the glucaric acid crosslinker. 
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Figure 27.  Undegraded Amygel.  
 
Figure 28.  Degraded Amygel. 
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      (a) 
     (c) 
    (b) 
  (d) 
Figure 29.  Amygel after Degradation in Cell Culture Media- (a) starch, (b) 0.25% 
crosslinked starch, (c) 0.5% crosslinked starch, and (d) 5% crosslinked starch. 
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From these two pieces of evidence, the changes in pH and the precipitation of 
particles, the gel appears to be a combination device of both the Chemically Controlled 
Release System and the Diffusion Controlled Release System described earlier in this 
text.  The two step theory of the degradation mechanism also lends itself to the idea 
manipulating the amounts of unreacted and reacted crosslink monomer to achieve 
constant or  zero order release kinetics also described earlier.   
It should also be noted that the 5% crosslinked gel remains a gel with some 
sedimentation of particles on the bottom of the test tube after the 5 day experimental 
period implying that the increased crosslink concentration has extended the degradation 
time of the 5% crosslinked gel.  This data may be evidence that the chemical bonding of 
the glucaric acid does play a role in reinforcing the network considering the network of 
the 5% crosslinked gel remains a network after the other samples have degraded into 
particles. 
The pH of cell culture solutions was measured during the course of the 5 day 
proliferation study, and changes in pH of solution were present.  The shifts in pH of the 
culture media are so slight, however, that the amount of acid being released from the 
system could not be quantified.   Although only slight changes were detected, the data 
does illustrate an obvious trend.  As illustrated in Figure 30.  
This slight shift from neutral is encouraging evidence for both the release of acid 
and also the idea that the cell proliferation is decreasing, as described in the next section, 
as an effect of the drug because these changes are so slight that cell death is probably not 
due to extreme environmental conditions.   
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Figure 30. Changes in pH of Cell Culture Media During Proliferation Study
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Cell Culture Studies  
 
   Although the colony studies were inconclusive because there were too many 
colonies to count, qualitative visual data was obtained from the fixed cells.  There appear 
to be no apparent differences in the cell morphology of treated versus untreated cells, as 
illustrated in the sample images in Figure 31 implying that the drug does not cause 
physical stress to the cells but instead induces some sort of cell cycle response. 
Additional images of the Colony Study cultures are presented in Appendix B. 
 The results of the growth assay are represented graphically below.   Figure 32 
represents the number of cells after 5 days exposure to glucaric acid alone.  From the 
figure, the varying concentrations of d-glucaric acid in the cell culture media affected the 
proliferation of the U2OS cells by 30-70%.  Figure 32 represents the growth curve of the 
U2OS cells exposed to the crosslinked gel.  250,000 cells were plated and allowed to rest 
for 24 hours before the addition of the crosslinked gel to the culture medium. The 
samples were then counted daily to estimate the number of cells in each plate. 
The growth curves of the control plates and the uncrosslinked starch plates appear 
similar.  The plot illustrates increased suppression of cell proliferation with increased 
glucaric acid crosslink concentration.  The 1% glucaric acid composition impedes cell 
proliferation of osteosarcomas by 70% after 4 days exposure.  Figures 33 and 34 are bar 
graphs comparing cell proliferation studies at the same time period.  Both cultures were 
treated with the same amount of glucaric acid.  In one culture, the glucaric acid was 
dissolved in the media and added to the culture.  In the second, the same amount of 
glucaric acid was reacted with starch, and the crosslinked starch gel was added to the 
culture media.  The decrease in cell proliferation of both treated samples appear similar.
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Figure 31.  Cell Cultures Exposed to Varying Concentrations of Glucaric Acid. 
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Figure 32.  Cell Proliferation During 5 Days Exposure to Amygel
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Figure 33.  Number of Cells after 3 Days Exposure to D-Glucaric Acid 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 34.  Number of Cells after 3 Days Exposure to Amygel 
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V.  Conclusions and Future Work 
Conclusions 
 
- A polymeric network of amylose and amylopectin, the main components of 
starch, was formed and chemically crosslinked with d-glucaric acid. 
- By crosslinking the amylose and amylopectin gel with d-glucaric acid the 
elastic modulus of the system increases. 
- By crosslinking the amylose and amylopectin gel with d-glucaric acid the 
degradation time of the gel is extended. 
- The amylose and amylopectin gel as well as the amylose and amylopectin gel 
crosslinked with d-glucaric acid, Amygel, are biodegradable. 
- Upon degradation, the chemical crosslinker, d-glucaric acid, present in 
Amygel is released from the system and decreases cell proliferation of human 
osteosarcoma cells. 
- Before degradation, unreacted d-glucaric acid is stored in the matrix of the 
hydrogel.  This drug is released upon diffusion out of the Amygel system and 
decreases the cell proliferation of human osteosarcoma cells.  
- Applications of Amygel include treating carcinogenic tumors by injecting 
Amygel in the proximity of the tumor and allowing the d-glucaric acid to decrease the 
size of the tumor or filling a wound where a tumor has been removed to prevent the 
metastasis of malignant cells that were not removed with the tumor. 
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Future Work 
 
 It is documented that the molecular machinery for producing glucaric acid is present in 
healthy cells and absent in cancerous ones.  Future work should include experiments with 
healthy cells to test the toxicity of excess glucaric acid in healthy tissues.  The foreseen 
application of the gel is as an injectable anti-tumor treatment and future work should include 
whole tumor cultures to measure the effects against a functioning tumor.  The next step after 
whole tumor cultures would be animal studies including mouse models. The gel should be 
analyzed with NMR to define the exact compounds of the system before and after degradation.  
Solution Neutron Scattering could also explore the physical and chemical structures of the 
network.  It is documented that starch is able to form complexes with other compounds, and 
neutron scattering could determine if the unreacted monomer is incorporated inside the helix of 
the starch polymers as other complexes in the literature.  Neutron scattering could also likely 
determine if the reacted glucaric acid crosslinker is bonded to the –OH groups on the outside of 
the starch helices. 
 Preparation methods incorporating microwave have been promising but as yet are 
unsuccessful as methods of producing the gels.  The microwaved gels appear more 
homogeneous but are not as strong as the ones produced with the traditional method.  
Microwaveable gels would be beneficial especially in a clinical setting where shelf life 
and storage of prepared gels could be problematic. 
   Other authors have used the Kiely method to purify the glucaric acid before 
incorporating the acid into various materials.  Future experiments utilizing this method of 
purification of the acid would increase reactivity of the acid and result in greater extent of 
the crosslinking reaction of the gels. 
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TITLE OF INVENTION
Hydrogel for Biomedical Applications 
BACKGROUND OF THE INVENTION
1. Field of Invention 
[0001] The invention relates to the field of delivery systems for biologically active 
agents. More specifically, the invention relates to the use of hydrogels for the delivery of 
biologically active agents. 
2. Description of the Related Art 
[0002] D-glucaric acid is a phytochemical (plant compound) that occurs naturally 
in the human body in very small amounts. Several laboratory and animal studies have found 
that D-glucaric acid seems to have some anti-cancer effects, among other 
beneficial effects. Many fruits and vegetables contain D-glucaric acid. Additionally, dietary 
supplements are commercially available that provide D-glucaric acid in the form 
of a salt, typically calcium D-glucarate. 
[0003] Following administration, D-glucaric acid is converted to at least two 
compounds: D-glucaro-1,4-lactone and D-glucaro-6,3-lactone. Many researchers believe that 
the former compound (D-glucaro-1,4-lactone) inhibits ~-glucuronidase, an enzyme that has 
been shown to decrease the rate of elimination of certain hormones and other 
chemicals from the body, including estrogen and various carcinogens. Accordingly, 
administration of D-glucaric acid is believed to increase the body's ability to eliminate 
carcinogens and excess hormones, thereby inhibiting (1) carcinogenesis, (2) malignant 
tumor growth, (3) metastasis, and (4) tumorigenesis. D-glucaric acid may also interact with 
signal transduction pathways. Some researchers suggest that D-glucaric acid's anti-cancer 
effects may arise also from its ability to interact with signal transduction 
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pathways. Still other researchers suggest that increased concentrations of D-glucaric acid 
aid in preventing mutations in at least one of the genes (i.e., ras) that codes for proteins that 
stimulate cell growth (e.g., K-Ras). Finally, still other researchers suggest that D-glucaric 
acid inhibits the ability of some mutagens (e.g., benzo[a]pyrene) to bind 
to DNA. 
[0004] A number of animal studies published in peer-reviewed medical journals 
have found that, in rats, dietary D-glucaric acid (1) inhibits the development of breast cancer 
tumors and (2) shrinks some existing tumors. Animal studies also found that dietary D-
glucaric acid slowed the development of tumors in the colon, lung, liver, skin, 
and prostate. 
[ 
0005] 
Other beneficial effects of D-glucaric acid, according to some researchers, 
include (1) increasing hepatic circulation, (2) decreasing lipid levels in the blood, (3) 
reducing cholesterol production, and (4) lowering estrogen levels. For example, 
preliminary human studies have shown that D-glucaric acid reduces total serum 
cholesterol up to 12 percent, low-density lipoprotein (LDL) up to 28 percent, triglycerides 
up to 43 percent. There are no known side effects associated with the use of D-glucaric acid.
[0006] In September, 2006, a scientific research article disclosed that D-glucaric 
acid lactones can readily be grafted onto primary positions of polyolsor polysaccharides 
under mild non-toxic conditions. c.-L. Davey, et al., Esterification of select polyols with D-glucaric 
acid as model reactions for esterification of starch, Carbohydrate Research, Vol. 341, (2006), pp. 
2688-2693. The objective of the research performed by 
Davey et al. was to determine to what extent some select polyols, as structural models for 
starch, could be directly esterified with D-glucaric acid, which (in aqueous solution) is in 
equilibrium as the acyclic diacid and the 1,4- and 6,3-D-glucaro lactones. Id., 2688. 
Davey et al. concluded that transesterification of D-glucaric acid lactones occurs readily 
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to unhindered primary hydroxyls of polyols and that the pendant D-glucaric acid groups 
are in the appropriate lactone form rather than in the open-chain acid (acyclic) form. Id., 
2689. Accordingly, those pendant lactones can further trans esterify to form linkages 
between different polyol molecules. Id. 
[0007] Although many medicines and other biologically active agents currently 
are available in a controlled-release formulation, there is no known controlled-release 
formulation for D-glucaric acid. It would be advantageous if D-glucaric acid were 
available in a controlled-release formulation. It would be advantageous also if such a 
formulation could be administered parenterally such that a specific location in the body could 
be targeted for treatment with D-glucaric acid. 
BRIEF SUMMARY OF THE INVENTION
[0008] A hydrogel for biomedical applications is disclosed herein. The hydrogel 
comprises a dispersed phase and a dispersion medium, the latter (dispersion medium) 
consisting substantially of water. In all embodiments disclosed herein, the dispersed phase 
includes a polymeric network having both hydrophilic properties and hydrophobic 
properties. In some embodiments, for example, the polymeric network includes a 
hydrolyzable starch-derived polymeric substance and a cross-link that has the potential to 
cause a biological effect following the controlled release in vivo of the 
cross-link from the hydrogel. In some of these embodiments, the cross-link includes D-
glucaric acid, a derivative of D-glucaric acid, or an analogue of D-glucaric acid. Among 
other things, a method is disclosed for increasing the concentration of a biologically 
active form of D-glucaric acid in a warm-blooded organism. 
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DESCRIPTION OF THE INVENTION
[0009] The present invention, i.e., a hydrogel for biomedical applications, is 
described more fully hereinafter. From the outset, it is worth noting that this invention may be 
embodied in many different forms and should not be construed as limited to the specific 
embodiments described herein. Additionally, the inventor's thesis titled, "The 
Synthesis and Characterization of a Novel Polysaccharide Hydrogel for Biomedical 
Applications," which as of yet is unpublished, is attached hereto as Appendix A and is 
incorporated into this specification. 
[0010] Definitions 
[0011] " Analogue" is a chemical compound with a structure similar to that of 
another but differing from it in respect to a certain component; it may have a similar or 
opposite action metabolically. 
[0012] "Biopolymer" is a polymeric substance (as a protein or polysaccharide) 
formed in a biological system. 
[0013] "Complex" is a molecular entity formed by loose association involving 
two or more component molecular entities (ionic or uncharged), or the corresponding 
chemical species. The bonding between the components is normally weaker than a covalent 
bond. 
[0014] "Derive" means to obtain (a chemical substance) actually or theoretically 
from a parent substance. 
[0015] "Parenteral administration" is any route of administration other than the 
alimentary canal, including, for example, subcutaneous and intramuscular. 
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[0016] "Polyol" is an alcohol containing more than two hydroxyl groups (e.g., 
suger alcohols, inositol). Also known as polyhydric alcohol. 
[0017] "Polysaccharide" is a carbohydrate that can be decomposed by hydrolysis 
into two or more molecules of monosaccharides; especially: one (as cellulose, starch, or 
glycogen) containing many monosaccharide units and marked by complexity. 
[0018] "Solvation" is any stabilizing interaction of a solute (or solute moiety) and 
the solvent or a similar interaction of solvent with groups of an insoluble substance. Such 
interactions generally involve electrostatic forces and van der Waals forces, as well as 
chemically more specific effects such as hydrogen bond formation. 
[0019] "Starch" is anyone of a group of carbohydrates or polysaccharides, of the 
general composition (C6HlOOS)n, occurring as organized or structural granules of varying 
size and markings in many plant cells; it hydrolyzes to several forms of dextrin and glucose; 
its chemical structure is not completely known, but the granules consist of concentric shells 
containing at least two fractions: an inner portion called amylose, and an outer portion called 
amylopectin. 
[0020] Other definitions will be presented as necessary in the description that follows.
[0021] Hydrogel for Biomedical Applications 
[0022] A "hydrogel" is a gel composed usually of one or more polymers 
suspended in water. It is a colloidal system in which the dispersed phase (colloid) has 
combined with the dispersion medium (water) to produce a viscous jelly-like product. In all 
embodiments of the present invention, the colloid includes a polymeric network having 
both hydrophilic surfaces and hydrophobic surfaces. The hydrophilic surfaces enable the 
polymeric network to retain water via intermolecular forces (e.g., hydrogen 
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bonding). The hydrophilic surfaces also increase the permeability of the polymeric network 
to water. In contrast, the hydrophobic surfaces reduce the water solubility of the polymeric 
network, thus promoting the ability of the polymeric network to interact with water (i.e., the 
dispersion medium) without being dissolved by it. 
[0023] In at least some embodiments of the present invention, the polymeric 
network is at least partially starch-derived in that it includes a biopolymer that is commonly 
present in naturally-occurring starch. More specifically, the polymeric network includes 
amylose and! or amylopectin. Amylose is a polysaccharide composed of unbranched chains 
of D-glucose units joined by a-l,4'-glycosidic linkages. In contrast, amylopectin is a branched 
polysaccharide. Like amylose, it is composed of 
chains of D-glucose units joined by a-l,4' -glycosidic linkages. Unlike amylose, however, 
amylopectin also contains a-l,6' -glycosidic linkages, which create branches in the 
polysaccharide. The ratio of amylose to amylopectin in a starch-derived hydrogel influences 
the properties of the polymeric network. Accordingly, the performance of 
the hydrogel can be altered by changing the ratio of amylose to amylopectin. For example, 
the susceptibility of the hydrogel to hydrolytic degradation can be altered by adjusting that 
ratio. 
[0024] Another factor affecting performance of a hydrogel is the degree of cross 
linking in the polymeric network. A "cross-link" is a crosswise connecting part (as an atom 
or group) that connects parallel chains in a complex chemical molecule (e.g., a polymer). In 
the majority of instances, a cross-link is a covalent structure, but the term is also used to 
describe sites of other chemical interactions (e.g., ionic interactions), portions of crystallites, 
and even physical entanglements. The cross-link.ing of starchderived polymeric networks is 
generally known in the art, and various methods have been used in making a hydrogel that 
comprises a cross-linked starch-derived polymeric network. For example, in one method, a 
mixture including the starch-derived polymeric network and water is heated to at least 
partially solubilize it (the starch 
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derived polymeric network). During heating, this polymeric network, which commonly 
includes amylose and amylopectin, partially unravels. Heating also encourages the helical 
regions of the polymeric network to uncoil. This unraveling and uncoiling of the polymeric 
network allows the water in the mixture to more readily 
permeate and solvate the network. Additionally, some of the glycosidic linkages in the 
network are hydrolyzed, further encouraging the unraveling/ uncoiling and, hence, the 
solvation of the network. As these processes continue, the network is dispersed in the 
water, thereby increasing the homogeneity of the mixture. After the homogeneity has 
increased sufficiently, a cross-linking agent is added to the mixture. The heating of the 
mixture continues, encouraging the cross-linking agent to bond to the polymeric 
network to yield a cross-linked starch-derived polymeric network. The temperature(s) 
attained at this stage of heating may vary depending, inter alia, on (1) the identity of 
the cross-linking agent, (2) the concentration of the cross-linking agent in the mixture, and 
(3) the desired degree of cross-linking in the polymeric network. Thereafter, the mixture is 
cooled, encouraging the polymer chains in the network to entangle and coil. At least some of 
the water present in the network upon commencement of the cooling is 
retained therein, leading to the formation of the hydrogel. 
[0025] In at least some embodiments of the present invention, the hydrogel 
comprises a polymeric network that is cross-linked. In some of these embodiments, the 
hydrogel comprises a starch-derived polymeric network that is covalently cross-linked using 
D-glucaric acid lactone (e.g., D-glucaro-1,4-lactone). For example, the carboxyl 
group of D-glucaro-1,4-lactone that includes the C-6 carbon can react with a primary 
hydroxyl group on a first polymer chain of amylose or amylopectin via an esterification 
reaction, thereby resulting in a covalent bond between the two. Additionally, the pendant 
lactone can react with a primary hydroxyl group on a second polymer chain of amylose or 
amylopectin via a transesterification reaction, resulting in a covalent bond between these two, 
thereby completing the cross-link. It is worth noting that these ester linkages are susceptible 
to hydrolysis, as are the glycosidic linkages in amylose, 
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amylopectin, and other polysaccharides. Accordingly, a hydrogel that comprises a starch-
derived polymeric network that is cross-linked via esterification using D-glucaro 
l,4-lactone is biodegradable, meaning that the hydrogel will erode or degrade in vivo, 
essentially yielding only biocompatible substances, including D-glucaro-l,4-lactone. It is 
worth noting also that this process can be used in preparing a starch-derived polymeric 
network that is cross-linked with D-glucaro-6,3-lactone. 
[0026] As indicated previously, there is a significant body of evidence tending to 
establish that D-glucaro-l,4-lactone is a biologically active agent. This body of evidence 
suggests that D-glucaro-l,4-lactone has anti-cancer effects, among other beneficial 
biomedical effects. The embodiments of the hydrogel that comprise a starch-derived 
polymeric network that is cross-linked with D-glucaric acid (e.g., D-glucaro-l,4-lactone) are 
among those suitable for parenteral administration to a warm-blooded organism. Such 
embodiments of the hydrogel can be used to increase the concentration of Dglucaric acid in 
the bloodstream. Furthermore, because such embodiments can be 
administered parenterally, they facilitate the selective targeting of a location in the organism 
such that, at least initially, the concentration of D-glucaric acid in that location can be 
increased substantially relative to the overall concentration of D-glucaric acid in the 
organism. Thus, for example, a hydrogel comprising a starch-derived polymeric network that 
is cross-linked with D-glucaric acid can be parenterally administered to a location proximate 
to a malignant tumor. 
[0027] In still other embodiments of the present invention, the hydrogel 
comprises a starch-derived polymeric network that is cross-linked with a biologically active 
form of D-glucaric acid (e.g., D-glucaro-l,4-lactone), the cross-link serves at least two 
purposes. In addition to causing a biological effect upon release from the hydrogel, such a 
cross-link alters the hydrogel's degradation properties. Accordingly, the degree of cross-
linking affects the release kinetics of the biologically active form of D-glucaric acid. A 
suitable degree of cross-linking can, for example, increase the reliability of the 
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performance of the hydrogel insofar as release kinetics are concerned. It is worth noting that, 
in this instance, the degree of cross-linking acquires even greater significance because it is 
directly related to dosage. Other factors affecting release kinetics include (1) the ratio of 
amylose to amylopectin (as indicated previously) and (2) the density of the hydrogel. Suitable 
formulations will be determined by one skilled in the art and will vary depending, inter alia, 
on (1) the route of administration, (2) the desired effect (e.g., anti-cancer), and (3) the desired 
release kinetics (e.g., sustained release and other types of controlled release). Such 
formulations may vary also depending on whether the desired biological effect is therapeutic, 
prophylactic, or diagnostic. 
[0028] In still other embodiments of the present invention, the dispersed phase 
(colloid) of the hydrogel includes at least three different chemical substances: (1) a starch-
derived polymeric network, (2) a cross-link, and (3) a biologically active agent. The starch-
derived polymeric network is cross-linked to facilitate the controlled release in vivo of the 
biologically active agent. In at least some of these embodiments, the starch-derived 
polymeric network is cross-linked also to facilitate the retention in vitro of the biologically 
active agent. For example, the cross-link can change the mechanical properties of the starch-
derived polymeric network, thereby enhancing the ability of the network to retain biologically 
active agents in some instances. Such changes can affect the helical regions of the starch-
derived polymeric network, allowing these regions to more readily accept and retain a 
biologically active agent (e.g., an antibiotic). It is worth noting that, in embodiments where 
the biologically active agent has complexed with the helical or other regions of the starch-
derived polymeric network, diffusion can be a 
significant factor in effecting the release of the biologically active agent from the 
hydrogel. Thus, one skilled in the art will consider the process of diffusion as well as the 
degradability of the hydrogel when formulating and designing such a hydrogel. 
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CLAIMS
Having thus described the aforementioned invention, what is claimed is: 
 1. A hydrogel for the controlled delivery of a biologically active agent, said 
hydrogel comprising: 
a dispersed phase including a polymeric network, said polymeric network having 
both hydrophilic properties and hydrophobic properties, said polymeric network including a 
hydrolyzable polymeric substance and a cross-link, said cross-link having the potential to 
cause a biological effect following the controlled release in vivo of said cross-link from said 
hydrogel; and 
a dispersion medium comprising water. 
 2. The hydrogel of Claim 1 wherein said hydrolyzable polymeric substance is 
at least partially derived from starch. 
 3. The hydrogel of Claim 1 wherein said hydrolyzable polymeric substance is a 
polyol or a polysaccharide. 
4. The hydrogel of Claim 1 wherein said hydrolyzable polymeric substance is 
selected from the group consisting of amylose, amylopectin, and any combination 
thereof. 
5. The hydrogel of Claim 1 wherein said cross-link includes D-glucaric acid, a 
derivative of D-glucaric acid, or an analogue of D-glucaric acid. 
6. A method of inhibiting B-glucuronidase, said method comprising the step of 
parenterally administering to a warm-blooded organism a hydrogel, said hydrogel including a 
polymeric network having both hydrophilic properties and hydrophobic properties, said 
polymeric network including a hydrolyzable polymeric substance and a 
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cross-link, said cross-link including D-glucaric acid, a derivative of D-glucaric acid, or an 
analogue of D-glucaric acid. 
7. The method of Claim 6 wherein said hydrolyzable polymeric substance is at least 
partially derived from starch. 
8. The hydrogel of Claim 6 wherein said hydrolyzable polymeric substance is a polyol 
or a polysaccharide. 
9. The hydrogel of Claim 6 wherein said hydrolyzable polymeric substance is 
selected from the group consisting of amylose, amylopectin, and any combination 
thereof. 
10. A method of increasing the concentration oIa biologically active form of D'" 
glucaric acid in a warm-blooded organism, said method comprising the step of parenterally 
administering to the warm-blood organism a hydrogel, said hydrogel including a polymeric 
network having both hydrophilic properties and hydrophobic properties, said polymeric 
network including a hydrolyzable polymeric substance and a 
cross-link, said cross-link including D-glucaric acid, a derivative of D-glucaric acid, or an 
analogue of D-glucaric acid. 
11. The method of Claim 10 wherein said hydrolyzable polymeric substance is at 
least partially derived from starch. 
12. The hydrogel of Claim 10 wherein said hydrolyzable polymeric substance is a 
polyol or a polysaccharide. 
13. The hydrogel of Claim 10 wherein said hydrolyzable polymeric substance is 
selected from the group consisting of amylose, amylopectin, and any combination 
thereof. 
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A hydrogel for biomedical applications is disclosed, as are various methods relating 
to its use. The hydrogel comprises a dispersed phase and a dispersion medium, the 
dispersion medium consisting substantially of water. In all embodiments disclosed herein, 
the dispersed phase includes a polymeric network. In some  
embodiments, the polymeric network includes a hydrolyzable polymeric substance and a 
cross-link that has the potential to cause a biological effect following the controlled release in 
vivo of the cross-link from the hydrogel. Among other things, a method is disclosed for using 
some embodiments of the hydrogel to increase the concentration of 
a biologically active form of D-glucaric acid in a warm-blooded organism. 
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